Fully implantable nerve signal sensing and stimulation device and method for treating foot drop and other neurological disorders
First Claim
1. A totally implantable nerve stimulation system, comprising:
- one or more nerve cuffs having electrodes therein that contact a nerve or nerves;
an event-triggered, closed-loop control unit that is connected to receive signals from at least one electrode in a nerve cuff and to deliver stimulation pulses to at least one electrode in order to produce a desired physiological response, the closed-loop control unit including;
an internal electrical power source;
a processor;
a number of signal conditioning circuits;
a programmable switch controlled by the processor to connect an electrode to a signal conditioning circuit;
at least one stimulation circuit that delivers a stimulation pulse to one or more of the electrodes;
wherein the processor selectively enables the number of signal conditioning circuits, the programmable switch and the at least one stimulation circuit to lengthen the life of the electrical power source.
7 Assignments
0 Petitions

Accused Products

Abstract
A fully implantable nerve stimulation system includes an event-triggered, closed-loop control unit that detects physiological events from nerve signals and delivers stimulation pulses to a nerve to produce a desired physiological response. The stimulation system includes a low-noise, low-power nerve signal amplifier, accelerometers that detect position and a battery powered processor that selectively powers components in the system to detect physiological events and deliver stimulation pulses with a minimum of battery power.
561 Citations
Transcutaneous analyte sensor | ||
Patent #
US 7,905,833 B2
Filed 06/21/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and method for regulating cardiopulmonary triggered therapy to the brain | ||
Patent #
US 7,865,244 B2
Filed 12/19/2005
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Implantable Electrical Stimulator | ||
Patent #
US 20110093036A1
Filed 10/20/2009
|
Current Assignee
Man Science S.A.
|
Original Assignee
Nyxoah SA
|
Diagnosis and Prediction of Obstructive Sleep Apnea | ||
Patent #
US 20110152965A1
Filed 12/21/2009
|
Current Assignee
Nyxoah SA
|
Original Assignee
Nyxoah SA
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20110137601A1
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20110124997A1
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TECHNIQUES FOR REDUCING PAIN ASSOCIATED WITH NERVE STIMULATION | ||
Patent #
US 20110137365A1
Filed 02/07/2011
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
BioControl Medical B.C.M Ltd.
|
System and method for monitoring or treating nervous system disorders | ||
Patent #
US 7,945,316 B2
Filed 12/19/2005
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 7,920,906 B2
Filed 03/09/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
ELECTRODE LEAD SYSTEM | ||
Patent #
US 20110160827A1
Filed 05/01/2009
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Obstructive Sleep Apnea Treatment Devices, Systems and Methods | ||
Patent #
US 20110160794A1
Filed 12/29/2010
|
Current Assignee
Cyberonics Inc
|
Original Assignee
Apnex Medical Inc.
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20110118579A1
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
ELECTRODE CUFFS | ||
Patent #
US 20110098796A1
Filed 11/16/2010
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
BioControl Medical B.C.M Ltd.
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20110130971A1
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20110118580A1
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated receiver for continuous analyte sensor | ||
Patent #
US 7,927,274 B2
Filed 07/29/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20110130970A1
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SELF EXPANDING ELECTRODE CUFF | ||
Patent #
US 20110147046A1
Filed 05/01/2009
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,010,174 B2
Filed 08/22/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20110231141A1
Filed 05/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20110218414A1
Filed 04/05/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSVENOUS METHOD OF TREATING SLEEP APNEA | ||
Patent #
US 20110202119A1
Filed 09/30/2009
|
Current Assignee
Inspire Medical Systems Inc.
|
Original Assignee
Inspire Medical Systems Inc.
|
NEEDLE PLACEMENT DETECTION AND SECURITY DEVICE AND METHOD | ||
Patent #
US 20110190682A1
Filed 01/29/2010
|
Current Assignee
Baxter International Inc., Baxter Healthcare SA
|
Original Assignee
Baxter International Inc., Baxter Healthcare SA
|
CATHETER NEEDLE RETENTION AND PLACEMENT MONITORING SYSTEM AND METHOD | ||
Patent #
US 20110190681A1
Filed 01/29/2010
|
Current Assignee
Baxter International Inc., Baxter Healthcare SA
|
Original Assignee
Baxter International Inc., Baxter Healthcare SA
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 7,998,071 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,005,524 B2
Filed 03/24/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Electrode contact configurations for cuff leads | ||
Patent #
US 7,974,706 B2
Filed 03/30/2006
|
Current Assignee
Boston Scientific Neuromodulation Corporation
|
Original Assignee
Boston Scientific Neuromodulation Corporation
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 7,976,492 B2
Filed 08/06/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Capacitive interface circuit for low power sensor system | ||
Patent #
US 8,000,789 B2
Filed 04/24/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Implantable medical device for treating neurological conditions including ECG sensing | ||
Patent #
US 8,000,788 B2
Filed 04/27/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Method and apparatus for detection of nervous system disorders | ||
Patent #
US 7,979,130 B2
Filed 02/21/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
OBSTRUCTIVE SLEEP APNEA TREATMENT DEVICES, SYSTEMS AND METHODS | ||
Patent #
US 20110196445A1
Filed 04/26/2011
|
Current Assignee
Cyberonics Inc
|
Original Assignee
Apnex Medical Inc.
|
ELECTRODE CONTACT CONFIGURATIONS FOR CUFF LEADS | ||
Patent #
US 20110224744A1
Filed 05/24/2011
|
Current Assignee
Boston Scientific Neuromodulation Corporation
|
Original Assignee
Boston Scientific Neuromodulation Corporation
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,052,601 B2
Filed 08/20/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for detection of nervous system disorders | ||
Patent #
US 8,068,903 B2
Filed 01/27/2010
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,060,173 B2
Filed 08/01/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and method for monitoring or treating nervous system disorders | ||
Patent #
US 8,041,419 B2
Filed 12/19/2005
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
System and method for regulating cardiac triggered therapy to the brain | ||
Patent #
US 8,041,418 B2
Filed 12/19/2005
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
System and method for regulating cardiopulmonary triggered therapy to the brain | ||
Patent #
US 8,068,911 B2
Filed 04/27/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Weight loss method and device | ||
Patent #
US 7,835,796 B2
Filed 04/29/2005
|
Current Assignee
LivaNova USA Inc.
|
Original Assignee
Cyberonics Inc
|
SYSTEMS AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100179408A1
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20100030053A1
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100030038A1
Filed 10/12/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
DEVICES AND METHODS FOR TREATING SLEEP DISORDERS | ||
Patent #
US 20100139667A1
Filed 11/24/2009
|
Current Assignee
Cyberonics Inc
|
Original Assignee
Apnex Medical Inc.
|
METHOD AND APPARATUS FOR OPTIMIZING VAGAL NERVE STIMULATION USING LARYNGEAL ACTIVITY | ||
Patent #
US 20100324628A1
Filed 08/31/2010
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Anthony V. Caparso, Mark Bly, Randy Westlund
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100016687A1
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA FOR SENSOR CALIBRATION | ||
Patent #
US 20100168546A1
Filed 01/07/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for optimizing vagal nerve stimulation using laryngeal activity | ||
Patent #
US 7,801,603 B2
Filed 09/01/2006
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA FOR SENSOR CALIBRATION | ||
Patent #
US 20100168545A1
Filed 01/07/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100228497A1
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100217557A1
Filed 01/20/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20100240975A1
Filed 06/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Mechanism and method of attaching a stimulation and/or sensing electrode to a nerve | ||
Patent #
US 7,787,959 B1
Filed 12/22/2006
|
Current Assignee
Pacesetter Incorporated
|
Original Assignee
Pacesetter Incorporated
|
INTEGRATED RECEIVER FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100016698A1
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Dressing and integrated system for detection of fluid loss | ||
Patent #
US 7,670,289 B1
Filed 08/01/2007
|
Current Assignee
Kenneth Shawn Mccall
|
Original Assignee
Kenneth Shawn Mccall
|
Devices and methods for treating sleep disorders | ||
Patent #
US 7,644,714 B2
Filed 05/23/2006
|
Current Assignee
LivaNova USA Inc.
|
Original Assignee
Apnex Medical Inc.
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100010324A1
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100191082A1
Filed 03/19/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for detection of nervous system disorders | ||
Patent #
US 7,764,989 B2
Filed 12/12/2006
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Obstructive sleep apnea treatment devices, systems and methods | ||
Patent #
US 7,809,442 B2
Filed 10/12/2007
|
Current Assignee
Cyberonics Inc
|
Original Assignee
Apnex Medical Inc.
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,826,981 B2
Filed 01/18/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100217555A1
Filed 12/16/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100174163A1
Filed 03/22/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Implantable medical device configured as a pedometer | ||
Patent #
US 7,844,336 B2
Filed 04/10/2007
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Electrode devices for nerve stimulation and cardiac sensing | ||
Patent #
US 20100042186A1
Filed 08/13/2008
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
BioControl Medical B.C.M Ltd.
|
Method and Apparatus for Detection of Nervous System Disorders | ||
Patent #
US 20100292753A1
Filed 06/15/2010
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100268047A1
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Blood loss detection for hemodialysis system | ||
Patent #
US 7,641,612 B1
Filed 01/17/2006
|
Current Assignee
Kenneth Shawn Mccall
|
Original Assignee
Kenneth Shawn Mccall
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100010332A1
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100010331A1
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20100036215A1
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20100036224A1
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DecCom Inc.
|
METHOD AND APPARATUS FOR DETECTION OF NERVOUS SYSTEM DISORDERS | ||
Patent #
US 20100130881A1
Filed 01/27/2010
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Shielded electrode assembly for effective nerve sensing and stimulation | ||
Patent #
US 7,751,880 B1
Filed 02/12/2007
|
Current Assignee
Pacesetter Incorporated
|
Original Assignee
Pacesetter Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA FOR SENSOR CALIBRATION | ||
Patent #
US 20100179402A1
Filed 03/26/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100174158A1
Filed 03/22/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for detection of nervous system disorders | ||
Patent #
US 7,761,146 B2
Filed 12/12/2006
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100179400A1
Filed 03/24/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100185069A1
Filed 03/30/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20100179409A1
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for detection of nervous system disorders | ||
Patent #
US 7,761,145 B2
Filed 12/12/2006
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100212583A1
Filed 05/06/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous medical device with variable stiffness | ||
Patent #
US 7,783,333 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100274111A1
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 7,857,760 B2
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Intra-Atrial parasympathetic stimulation | ||
Patent #
US 20090005845A1
Filed 02/01/2008
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20090012379A1
Filed 08/20/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and Methods for Treating Neurological Disorders by Light Stimulation | ||
Patent #
US 20090054955A1
Filed 08/20/2008
|
Current Assignee
Harry T. Whelan, Brian H. Kopell, Thomas E. Prieto, Mark S. Geisler
|
Original Assignee
Harry T. Whelan, Brian H. Kopell, Thomas E. Prieto, Mark S. Geisler
|
ANALYTE SENSOR | ||
Patent #
US 20090036763A1
Filed 10/14/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090043542A1
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090043541A1
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090043182A1
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090043525A1
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090043181A1
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20090076361A1
Filed 11/18/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090062635A1
Filed 11/03/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20090124877A1
Filed 01/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Shielded electrode for nerve sensing | ||
Patent #
US 7,536,227 B1
Filed 01/26/2005
|
Current Assignee
Pacesetter Incorporated
|
Original Assignee
Pacesetter Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20090156919A1
Filed 02/26/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR EXTENDING THE USEFUL LIFE OF OPTICAL SENSORS | ||
Patent #
US 20090146078A1
Filed 05/19/2008
|
Current Assignee
Senseonics Incorporated
|
Original Assignee
Sensors For Medicine and Science Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20090192724A1
Filed 02/03/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR PROCESSING SENSOR DATA | ||
Patent #
US 20090192380A1
Filed 10/24/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090171179A1
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090187088A1
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090177064A1
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090216101A1
Filed 02/13/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090203981A1
Filed 04/15/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
ANALYTE SENSOR | ||
Patent #
US 20090242399A1
Filed 03/25/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SELF EXPANDING ELECTRODE CUFF | ||
Patent #
US 20090276024A1
Filed 05/02/2008
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
POSTURE SENSOR AUTOMATIC CALIBRATION | ||
Patent #
US 20090312973A1
Filed 04/16/2009
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090299162A1
Filed 07/24/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20080021666A1
Filed 10/01/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
METHOD AND APPARATUS FOR DETECTION OF NERVOUS SYSTEM DISORDERS | ||
Patent #
US 20080046024A1
Filed 12/12/2006
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL DATA ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20080033254A1
Filed 06/13/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHOD FOR REGULATING CARDIOPULMONARY TRIGGERED THERAPY TO THE BRAIN | ||
Patent #
US 20080033490A1
Filed 04/27/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
METHOD AND APPARATUS FOR OPTIMIZING VAGAL NERVE STIMULATION USING LARYNGEAL ACTIVITY | ||
Patent #
US 20080058874A1
Filed 09/01/2006
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Nerve cuff, method and apparatus for manufacturing same | ||
Patent #
US 20080065184A1
Filed 06/04/2007
|
Current Assignee
4491343 Canada Inc.
|
Original Assignee
4491343 Canada Inc.
|
Intravascular Stimulation System With Wireless Power Supply | ||
Patent #
US 20080077184A1
Filed 09/27/2006
|
Current Assignee
Kenergy Inc.
|
Original Assignee
Kenergy Inc.
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20080071156A1
Filed 10/26/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHOD FOR NEURO-STIMULATION | ||
Patent #
US 20080077192A1
Filed 10/29/2007
|
Current Assignee
Afferent Corporation
|
Original Assignee
Afferent Corporation
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20080091096A1
Filed 11/16/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Capacitive interface circuit for low power sensor system | ||
Patent #
US 20080079444A1
Filed 04/24/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Implantable medical device with sensor self-test feature | ||
Patent #
US 20080081958A1
Filed 04/24/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Obstructive sleep apnea treatment devices, systems and methods | ||
Patent #
US 20080103407A1
Filed 10/12/2007
|
Current Assignee
Cyberonics Inc
|
Original Assignee
Apnex Medical Inc.
|
Obstructive sleep apnea treatment devices, systems and methods | ||
Patent #
US 20080103545A1
Filed 10/12/2007
|
Current Assignee
LivaNova USA Inc.
|
Original Assignee
Apnex Medical Inc.
|
Selective nerve fiber stimulation for treating heart conditions | ||
Patent #
US 20080125827A1
Filed 10/29/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
BioControl Medical B.C.M Ltd.
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20080183399A1
Filed 04/04/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20080188731A1
Filed 04/11/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20080189051A1
Filed 04/07/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Variable antenna matching network for an implantable antenna | ||
Patent #
US 7,409,245 B1
Filed 01/30/2007
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20080214915A1
Filed 04/11/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
IMPLANTABLE MEDICAL DEVICE CONFIGURED AS A PEDOMETER | ||
Patent #
US 20080255626A1
Filed 04/10/2007
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Implantable medical device for treating neurological conditions with an initially disabled cardiac therapy port and leadless ECG sensing | ||
Patent #
US 20080269842A1
Filed 04/27/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
VARIABLE ANTENNA MATCHING NETWORK FOR AN IMPLANTABLE ANTENNA | ||
Patent #
US 20080288028A1
Filed 07/30/2008
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
INTEGRATED RECEIVER FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20080287764A1
Filed 07/29/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20080275313A1
Filed 07/17/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Multipolar stimulation electrode with mating structures for gripping targeted tissue | ||
Patent #
US 7,467,016 B2
Filed 01/27/2006
|
Current Assignee
LivaNova USA Inc.
|
Original Assignee
Cyberonics Inc
|
INTEGRATED MEDICAMENT DELIVERY DEVICE FOR USE WITH CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20080306435A1
Filed 06/05/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for processing analyte sensor data | ||
Patent #
US 20070016381A1
Filed 09/01/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 20070032706A1
Filed 08/02/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 20070027370A1
Filed 08/10/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20070191699A1
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20070203411A1
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20070179370A1
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20070203410A1
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Multipolar stimulation electrode | ||
Patent #
US 20070179580A1
Filed 01/27/2006
|
Current Assignee
LivaNova USA Inc.
|
Original Assignee
Cyberonics Inc
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20070208247A1
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and Apparatus for the Treatment of Movement Disorders | ||
Patent #
US 20070225674A1
Filed 11/30/2006
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20070208246A1
Filed 04/11/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
ANALYTE MONITORING DEVICE AND METHODS OF USE | ||
Patent #
US 20070244380A1
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
METHOD AND APPARATUS FOR DETECTION OF NERVOUS SYSTEM DISORDERS | ||
Patent #
US 20070249954A1
Filed 12/12/2006
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
SYSTEM AND METHOD FOR MONITORING OR TREATING NERVOUS SYSTEM DISORDERS | ||
Patent #
US 20070238939A1
Filed 04/27/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
METHOD AND APPARATUS FOR DETECTION OF NERVOUS SYSTEM DISORDERS | ||
Patent #
US 20070249953A1
Filed 12/12/2006
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
SYSTEM AND METHOD FOR REGULATING CARDIAC TRIGGERED THERAPY TO THE BRAIN | ||
Patent #
US 20070239060A1
Filed 04/27/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Electrode contact configurations for cuff leads | ||
Patent #
US 20070239243A1
Filed 03/30/2006
|
Current Assignee
Boston Scientific Neuromodulation Corporation
|
Original Assignee
Advanced Bionics Corporation
|
ANALYTE MONITORING DEVICE AND METHODS OF USE | ||
Patent #
US 20070249919A1
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
COLLECTING GAIT INFORMATION FOR EVALUATION AND CONTROL OF THERAPY | ||
Patent #
US 20070250134A1
Filed 03/26/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
ANALYTE MONITORING DEVICE AND METHODS OF USE | ||
Patent #
US 20070249920A1
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
SYSTEM AND METHOD FOR MONITORING OR TREATING NERVOUS SYSTEM DISORDERS | ||
Patent #
US 20070239054A1
Filed 04/27/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
METHOD AND APPARATUS FOR DETECTION OF NERVOUS SYSTEM DISORDERS | ||
Patent #
US 20070249956A1
Filed 12/12/2006
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
METHOD AND APPARATUS FOR DETECTION OF NERVOUS SYSTEM DISORDERS | ||
Patent #
US 20070265544A1
Filed 12/12/2006
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
System and method for utilizing brain state information to modulate cardiac therapy | ||
Patent #
US 20070260286A1
Filed 04/27/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
SYSTEM AND METHOD FOR MONITORING CARDIAC SIGNAL ACTIVITY IN PATIENTS WITH NERVOUS SYSTEM DISORDERS | ||
Patent #
US 20070260147A1
Filed 06/22/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
System and method for segmenting a cardiac signal based on brain stimulation | ||
Patent #
US 20070265536A1
Filed 04/27/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Transcutaneous medical device with variable stiffness | ||
Patent #
US 20060015024A1
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060020191A1
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060020188A1
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Apparatus and methods for calculating caloric expenditure using posture | ||
Patent #
US 20060015149A1
Filed 07/16/2004
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060036144A1
Filed 06/21/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060036143A1
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060036140A1
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 20060142651A1
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and method for monitoring or treating nervous system disorders | ||
Patent #
US 20060135877A1
Filed 12/19/2005
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Analyte sensor | ||
Patent #
US 20060155180A1
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 20060189863A1
Filed 11/01/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and method for regulating cardiopulmanary triggered therapy to the brain | ||
Patent #
US 20060195144A1
Filed 12/19/2005
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Analyte sensor | ||
Patent #
US 20060183985A1
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHOD FOR SEGMENTING A CARDIAC SIGNAL BASED ON BRAIN ACTIVITY | ||
Patent #
US 20060224067A1
Filed 04/27/2006
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Devices and methods for treating sleep disorders | ||
Patent #
US 20060266369A1
Filed 05/23/2006
|
Current Assignee
LivaNova USA Inc.
|
Original Assignee
Prospex Medical Inc.
|
Weight loss method and advice | ||
Patent #
US 20060247719A1
Filed 04/29/2005
|
Current Assignee
LivaNova USA Inc.
|
Original Assignee
Cyberonics Inc
|
Method and system for analyzing status of balance functions in patients with acute neurological disorders | ||
Patent #
US 20060264786A1
Filed 05/20/2005
|
Current Assignee
Neurocom International Inc.
|
Original Assignee
Neurocom International Inc.
|
Analyte sensor | ||
Patent #
US 20060270923A1
Filed 05/23/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 20050027180A1
Filed 08/01/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHOD FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20050187720A1
Filed 01/18/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 20040171921A1
Filed 02/27/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and method for segmenting a cardiac signal based on brain activity | ||
Patent #
US 8,108,038 B2
Filed 04/27/2006
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,073,519 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and method for using cardiac events to trigger therapy for treating nervous system disorders | ||
Patent #
US 8,108,046 B2
Filed 06/22/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Device | ||
Patent #
US 20120041513A1
Filed 11/21/2005
|
Current Assignee
Sky Medical Technology Ltd
|
Original Assignee
Skytech Medical Ltd.
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,073,520 B2
Filed 05/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and method for monitoring cardiac signal activity in patients with nervous system disorders | ||
Patent #
US 8,112,148 B2
Filed 06/22/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
System and method for monitoring or treating nervous system disorders | ||
Patent #
US 8,112,153 B2
Filed 04/27/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,128,562 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,150,488 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,162,829 B2
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Posture sensor automatic calibration | ||
Patent #
US 8,165,840 B2
Filed 04/16/2009
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Method and apparatus for detection of nervous system disorders | ||
Patent #
US 8,165,683 B2
Filed 12/12/2006
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,167,801 B2
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Variable antenna matching network for an implantable antenna | ||
Patent #
US 8,174,460 B2
Filed 07/30/2008
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,175,673 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,177,716 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Apparatus and methods for calculating caloric expenditure using posture | ||
Patent #
US 8,185,201 B2
Filed 07/16/2004
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
ELECTRODE CUFF WITH RECESSES | ||
Patent #
US 20120130463A1
Filed 11/22/2010
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
BioControl Medical B.C.M Ltd.
|
Method and apparatus for the treatment of movement disorders | ||
Patent #
US 8,190,251 B2
Filed 11/30/2006
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,195,265 B2
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,206,297 B2
Filed 12/16/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and method for utilizing brain state information to modulate cardiac therapy | ||
Patent #
US 8,214,035 B2
Filed 04/27/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Nerve cuff, method and apparatus for manufacturing same | ||
Patent #
US 8,214,056 B2
Filed 06/04/2007
|
Current Assignee
4491343 Canada Inc.
|
Original Assignee
Neurostream Technologies General Partnership
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,216,139 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,224,413 B2
Filed 10/10/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,558 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,557 B2
Filed 12/28/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,555 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,229,536 B2
Filed 05/27/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,229,534 B2
Filed 10/26/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,231,532 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for processing analyte sensor data | ||
Patent #
US 8,233,959 B2
Filed 09/01/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,233,958 B2
Filed 10/12/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
CUFF ELECTRODE HAVING TUBULAR BODY WITH CONTROLLED CLOSING FORCE | ||
Patent #
US 20120197371A1
Filed 03/06/2012
|
Current Assignee
Advanced Neuromodulation Systems Incorporated
|
Original Assignee
Advanced Neuromodulation Systems Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,235,896 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Dressing and integrated system for detection of fluid loss | ||
Patent #
US 8,235,930 B1
Filed 10/28/2009
|
Current Assignee
Kenneth Shawn Mccall
|
Original Assignee
Kenneth Shawn Mccall
|
Implantable medical device configured as a pedometer | ||
Patent #
US 8,249,715 B2
Filed 10/26/2010
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,251,906 B2
Filed 04/15/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,255,031 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,257,259 B2
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,260,392 B2
Filed 06/09/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal data artifacts in a glucose sensor data stream | ||
Patent #
US 8,260,393 B2
Filed 06/13/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,265,726 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,265,725 B2
Filed 10/12/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,273,022 B2
Filed 02/13/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,275,439 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Integrated receiver for continuous analyte sensor | ||
Patent #
US 8,282,550 B2
Filed 07/29/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,282,549 B2
Filed 12/08/2004
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,287,454 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 8,287,453 B2
Filed 11/07/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for optimizing vagal nerve stimulation using laryngeal activity | ||
Patent #
US 8,290,584 B2
Filed 08/31/2010
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,290,560 B2
Filed 11/18/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,290,561 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,292,810 B2
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,306,598 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Obstructive sleep apnea treatment devices, systems and methods | ||
Patent #
US 8,311,645 B2
Filed 04/26/2011
|
Current Assignee
Cyberonics Inc
|
Original Assignee
Apnex Medical Inc.
|
Self expanding electrode cuff | ||
Patent #
US 8,340,785 B2
Filed 05/02/2008
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,336 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,337 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,346,338 B2
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
POWER MANAGEMENT IN TRANSCRANIAL MAGNETIC STIMULATORS | ||
Patent #
US 20130006039A1
Filed 02/08/2011
|
Current Assignee
Rio Grande Neurosciences Inc.
|
Original Assignee
Rio Grande Neurosciences Inc.
|
Capacitive interface circuit for low power sensor system | ||
Patent #
US 8,352,030 B2
Filed 07/13/2011
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,353,829 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,357,091 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,366,614 B2
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,372,005 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,374,667 B2
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,380,273 B2
Filed 04/11/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Screening devices and methods for obstructive sleep apnea therapy | ||
Patent #
US 8,386,046 B2
Filed 10/03/2011
|
Current Assignee
Cyberonics Inc
|
Original Assignee
Apnex Medical Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,391,945 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,394,021 B2
Filed 10/01/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Early warning and shutdown system for hemodialysis | ||
Patent #
US 8,398,575 B1
Filed 12/03/2009
|
Current Assignee
Kenneth Shawn Mccall
|
Original Assignee
Kenneth Shawn Mccall
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,409,131 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,412,301 B2
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Devices and Methods for Delivering Energy as a Function of Condition Severity | ||
Patent #
US 20130085541A1
Filed 09/28/2012
|
Current Assignee
Nyxoah SA
|
Original Assignee
Adi Mashiach
|
Obstructive sleep apnea treatment devices, systems and methods | ||
Patent #
US 8,417,343 B2
Filed 10/12/2007
|
Current Assignee
LivaNova USA Inc.
|
Original Assignee
Apnex Medical Inc.
|
Systems and methods for processing sensor data | ||
Patent #
US 8,423,113 B2
Filed 10/24/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Electrode contact configurations for cuff leads | ||
Patent #
US 8,423,157 B2
Filed 05/24/2011
|
Current Assignee
Boston Scientific Neuromodulation Corporation
|
Original Assignee
Boston Scientific Neuromodulation Corporation
|
Obstructive sleep apnea treatment devices, systems and methods | ||
Patent #
US 8,428,727 B2
Filed 04/25/2011
|
Current Assignee
LivaNova USA Inc.
|
Original Assignee
Apnex Medical Inc.
|
Nerve cuff, method and apparatus for manufacturing same | ||
Patent #
US 8,428,749 B2
Filed 06/01/2012
|
Current Assignee
4491343 Canada Inc.
|
Original Assignee
Neurostream Technologies General Partnership
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,435,179 B2
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,442,610 B2
Filed 08/21/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Catheter needle retention and placement monitoring system and method | ||
Patent #
US 8,444,585 B2
Filed 01/29/2010
|
Current Assignee
Baxter International Inc., Baxter Healthcare SA
|
Original Assignee
Baxter International Inc., Baxter Healthcare SA
|
Transcutaneous analyte sensor | ||
Patent #
US 8,457,708 B2
Filed 12/05/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,463,350 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,465,425 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,469,886 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,473,021 B2
Filed 07/31/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,474,397 B2
Filed 05/06/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,475,373 B2
Filed 07/17/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,480,580 B2
Filed 04/19/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,483,791 B2
Filed 04/11/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and method for monitoring or treating nervous system disorders | ||
Patent #
US 8,485,979 B2
Filed 04/27/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,491,474 B2
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Electrode devices with resistive elements | ||
Patent #
US 8,494,655 B2
Filed 10/12/2011
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
BioControl Medical B.C.M Ltd.
|
Obstructive sleep apnea treatment devices, systems and methods | ||
Patent #
US 8,498,712 B2
Filed 12/29/2010
|
Current Assignee
Cyberonics Inc
|
Original Assignee
Apnex Medical Inc.
|
Systems and methods for extending the useful life of optical sensors | ||
Patent #
US 8,502,167 B2
Filed 05/19/2008
|
Current Assignee
Senseonics Incorporated
|
Original Assignee
Sensors For Medicine and Science Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,515,519 B2
Filed 02/26/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,515,516 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for detection of nervous system disorders | ||
Patent #
US 8,527,039 B2
Filed 07/06/2011
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
NEUROSTIMULATION SYSTEM FOR PREVENTING MAGNETICALLY INDUCED CURRENTS IN ELECTRONIC CIRCUITRY | ||
Patent #
US 20130245723A1
Filed 03/13/2013
|
Current Assignee
Boston Scientific Neuromodulation Corporation
|
Original Assignee
Boston Scientific Neuromodulation Corporation
|
Transcutaneous analyte sensor | ||
Patent #
US 8,548,551 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,548,553 B2
Filed 06/22/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TIBIAL NERVE STIMULATION | ||
Patent #
US 20130268023A1
Filed 12/15/2011
|
Current Assignee
Ams Research Corporation
|
Original Assignee
Ams Research Corporation
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 8,560,037 B2
Filed 03/26/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,565,849 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Electrode cuff with recesses | ||
Patent #
US 8,565,896 B2
Filed 11/22/2010
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
BioControl Medical B.C.M Ltd.
|
Integrated medicament delivery device for use with continuous analyte sensor | ||
Patent #
US 8,562,558 B2
Filed 06/05/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Techniques for reducing pain associated with nerve stimulation | ||
Patent #
US 8,571,651 B2
Filed 02/07/2011
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
BioControl Medical B.C.M Ltd.
|
Transcutaneous analyte sensor | ||
Patent #
US 8,571,625 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Apparatus and method for detecting a sleep disordered breathing precursor | ||
Patent #
US 8,574,164 B2
Filed 09/28/2012
|
Current Assignee
Nyxoah SA
|
Original Assignee
Nyxoah SA
|
Modulator apparatus configured for implantation | ||
Patent #
US 8,577,465 B2
Filed 09/28/2012
|
Current Assignee
Nyxoah SA
|
Original Assignee
Nyxoah SA
|
System and method for nerve modulation using noncontacting electrodes | ||
Patent #
US 8,577,466 B2
Filed 09/28/2012
|
Current Assignee
Nyxoah SA
|
Original Assignee
Nyxoah SA
|
Apparatus and method for controlling energy delivery as a function of degree of coupling | ||
Patent #
US 8,577,467 B2
Filed 09/28/2012
|
Current Assignee
Nyxoah SA
|
Original Assignee
Nyxoah SA
|
Systems and methods for determining a sleep disorder based on positioning of the tongue | ||
Patent #
US 8,577,472 B2
Filed 09/28/2012
|
Current Assignee
Nyxoah SA
|
Original Assignee
Nyxoah SA
|
Apparatus and methods for feedback-based nerve modulation | ||
Patent #
US 8,577,464 B2
Filed 09/28/2012
|
Current Assignee
Nyxoah SA
|
Original Assignee
Nyxoah SA
|
Apparatus and method for extending implant life using a dual power scheme | ||
Patent #
US 8,577,468 B2
Filed 09/28/2012
|
Current Assignee
Nyxoah SA
|
Original Assignee
Nyxoah SA
|
Antenna providing variable communication with an implant | ||
Patent #
US 8,577,478 B2
Filed 09/28/2012
|
Current Assignee
Nyxoah SA
|
Original Assignee
Nyxoah SA
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 8,579,816 B2
Filed 01/07/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Diagnosis and prediction of obstructive sleep apnea | ||
Patent #
US 8,585,617 B2
Filed 12/21/2009
|
Current Assignee
Nyxoah SA
|
Original Assignee
Nyxoah SA
|
Device and method for modulating nerves using parallel electric fields | ||
Patent #
US 8,588,941 B2
Filed 09/28/2012
|
Current Assignee
Nyxoah SA
|
Original Assignee
Nyxoah SA
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,597,189 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Cuff electrode having tubular body with controlled closing force | ||
Patent #
US 8,612,025 B2
Filed 03/06/2012
|
Current Assignee
Advanced Neuromodulation Systems Incorporated
|
Original Assignee
Advanced Neuromodulation Systems Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,612,159 B2
Filed 02/16/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Electrode devices for nerve stimulation and cardiac sensing | ||
Patent #
US 8,615,294 B2
Filed 08/13/2008
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
BioControl Medical B.C.M Ltd.
|
Analyte sensor | ||
Patent #
US 8,615,282 B2
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 8,611,978 B2
Filed 01/07/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,617,071 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,622,906 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Obstructive sleep apnea treatment devices, systems and methods | ||
Patent #
US 8,626,304 B2
Filed 12/29/2010
|
Current Assignee
Cyberonics Inc
|
Original Assignee
Cyberonics Inc
|
Obstructive sleep apnea treatment devices, systems and methods | ||
Patent #
US 8,639,354 B2
Filed 10/03/2011
|
Current Assignee
Cyberonics Inc
|
Original Assignee
Cyberonics Inc
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,641,619 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Electrode configuration for implantable modulator | ||
Patent #
US 8,644,957 B2
Filed 09/28/2012
|
Current Assignee
Nyxoah SA
|
Original Assignee
Nyxoah SA
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,649,841 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,652,043 B2
Filed 07/20/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,657,745 B2
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for processing analyte sensor data | ||
Patent #
US 8,657,747 B2
Filed 04/05/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,660,627 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,666,469 B2
Filed 11/16/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,668,645 B2
Filed 01/03/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,670,815 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,672,844 B2
Filed 02/27/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for processing analyte sensor data | ||
Patent #
US 8,672,845 B2
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Apparatus and method for calculating caloric expenditure using posture | ||
Patent #
US 8,676,316 B2
Filed 05/15/2012
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,688,188 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,690,775 B2
Filed 04/11/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Devices and methods for low current neural modulation | ||
Patent #
US 8,700,183 B2
Filed 09/28/2012
|
Current Assignee
Nyxoah SA
|
Original Assignee
Nyxoah SA
|
System and method for segmenting a cardiac signal based on brain stimulation | ||
Patent #
US 8,209,009 B2
Filed 04/27/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
System and method for utilizing brain state information to modulate cardiac therapy | ||
Patent #
US 8,209,019 B2
Filed 04/27/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Apparatus and method to control an implant | ||
Patent #
US 8,718,776 B2
Filed 09/28/2012
|
Current Assignee
Nyxoah SA
|
Original Assignee
Nyxoah SA
|
Electrode cuffs | ||
Patent #
US 8,718,791 B2
Filed 11/16/2010
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
BioControl Medical B.C.M Ltd.
|
Obstructive sleep apnea treatment devices, systems and methods | ||
Patent #
US 8,718,783 B2
Filed 12/15/2011
|
Current Assignee
Cyberonics Inc
|
Original Assignee
Cyberonics Inc
|
Transcutaneous analyte sensor | ||
Patent #
US 8,721,545 B2
Filed 03/22/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 8,721,585 B2
Filed 03/30/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
Dex Com Inc.
|
Electrode device with elongated electrode | ||
Patent #
US 8,725,271 B2
Filed 07/11/2013
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
BioControl Medical B.C.M Ltd.
|
Transcutaneous analyte sensor | ||
Patent #
US 8,731,630 B2
Filed 03/22/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,348 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,346 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,738,109 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Medical device for isometric stimulation to improve blood flow | ||
Patent #
US 8,738,143 B2
Filed 11/21/2005
|
Current Assignee
Sky Medical Technology Ltd
|
Original Assignee
Sky Medical Technology Ltd
|
Method for monitoring or treating nervous system disorders | ||
Patent #
US 8,744,562 B2
Filed 12/10/2010
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Collecting gait information for evaluation and control of therapy | ||
Patent #
US 8,744,587 B2
Filed 03/26/2007
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Obstructive sleep apnea treatment devices, systems and methods | ||
Patent #
US 8,744,589 B2
Filed 12/29/2010
|
Current Assignee
Cyberonics Inc
|
Original Assignee
Cyberonics Inc
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,744,545 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,747,315 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,761,856 B2
Filed 04/27/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method for monitoring or treating nervous system disorders | ||
Patent #
US 8,761,868 B2
Filed 12/10/2010
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,774,888 B2
Filed 01/20/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,774,887 B2
Filed 03/24/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,777,853 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,788,008 B2
Filed 05/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,790,260 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,792,954 B2
Filed 03/19/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,792,955 B2
Filed 06/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,795,177 B2
Filed 01/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Electrode configuration for implantable modulator | ||
Patent #
US 8,798,773 B2
Filed 12/30/2013
|
Current Assignee
Man Science S.A.
|
Original Assignee
Man Science S.A.
|
Transcutaneous analyte sensor | ||
Patent #
US 8,801,611 B2
Filed 03/22/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,801,612 B2
Filed 04/27/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,801,610 B2
Filed 07/24/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,808,182 B2
Filed 04/27/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Needle placement detection and security device and method | ||
Patent #
US 8,808,218 B2
Filed 01/29/2010
|
Current Assignee
Baxter International Inc., Baxter Healthcare SA
|
Original Assignee
Baxter International Inc., Baxter Healthcare SA
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,812,073 B2
Filed 06/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
METHOD AND APPARATUS FOR MEASUREMENT OF NEURAL RESPONSE | ||
Patent #
US 20140236042A1
Filed 05/11/2012
|
Current Assignee
Saluda Medical Pty Ltd.
|
Original Assignee
Saluda Medical Pty Ltd.
|
Posture sensor automatic calibration | ||
Patent #
US 8,818,748 B2
Filed 04/02/2012
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,821,400 B2
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,825,127 B2
Filed 05/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,840,553 B2
Filed 02/26/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,843,187 B2
Filed 06/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,845,536 B2
Filed 04/11/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Screening devices and methods for obstructive sleep apnea therapy | ||
Patent #
US 8,855,771 B2
Filed 08/08/2011
|
Current Assignee
Cyberonics Inc
|
Original Assignee
Cyberonics Inc
|
Transcutaneous analyte sensor | ||
Patent #
US 8,858,434 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,880,137 B2
Filed 04/18/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Electrode cuffs | ||
Patent #
US 8,880,192 B2
Filed 04/02/2012
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
BioControl Medical B.C.M Ltd.
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 8,882,741 B2
Filed 04/30/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 8,886,272 B2
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,915,849 B2
Filed 02/03/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,915,850 B2
Filed 03/28/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,920,319 B2
Filed 12/28/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 8,920,401 B2
Filed 04/30/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Electrode configuration for implantable modulator | ||
Patent #
US 8,929,999 B2
Filed 05/28/2014
|
Current Assignee
Man Science S.A.
|
Original Assignee
Adi Maschiach
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 8,926,585 B2
Filed 03/30/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Nerve cuff | ||
Patent #
US 8,934,992 B2
Filed 08/31/2012
|
Current Assignee
Inspire Medical Systems Inc.
|
Original Assignee
Inspire Medical Systems Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,974,386 B2
Filed 11/01/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,986,209 B2
Filed 07/13/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Apparatus and method for controlling energy delivery as a function of degree of coupling | ||
Patent #
US 8,989,868 B2
Filed 09/30/2013
|
Current Assignee
Man Science S.A.
|
Original Assignee
Hyllio SA
|
Transcutaneous analyte sensor | ||
Patent #
US 8,989,833 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,332 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,331 B2
Filed 12/29/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,014,773 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Implantable medical device for treating neurological conditions including ECG sensing | ||
Patent #
US 9,014,804 B2
Filed 06/10/2011
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,042,953 B2
Filed 03/02/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,044,199 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Apparatus and method for extending implant life using a dual power scheme | ||
Patent #
US 9,044,612 B2
Filed 09/30/2013
|
Current Assignee
Man Science S.A.
|
Original Assignee
Carsten Mueller, Adi Mashiach
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 9,050,413 B2
Filed 04/30/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,060,742 B2
Filed 03/19/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Apparatus and method to control an implant | ||
Patent #
US 9,061,151 B2
Filed 03/24/2014
|
Current Assignee
Man Science S.A.
|
Original Assignee
Carsten Mueller, Adi Mashiach
|
MEDICAL DEVICE COMMUNICATION AND CHARGING ASSEMBLIES FOR USE WITH IMPLANTABLE SIGNAL GENERATORS, AND ASSOCIATED SYSTEMS AND METHODS | ||
Patent #
US 20150174409A1
Filed 12/22/2014
|
Current Assignee
Nevro Corporation
|
Original Assignee
Nevro Corporation
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,695 B2
Filed 04/12/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,697 B2
Filed 10/27/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,694 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,072,477 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,078,626 B2
Filed 03/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,078,607 B2
Filed 06/17/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 9,078,608 B2
Filed 07/13/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,107,623 B2
Filed 04/15/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Screening devices and methods for obstructive sleep apnea therapy | ||
Patent #
US 9,113,838 B2
Filed 09/02/2014
|
Current Assignee
LivaNova USA Inc.
|
Original Assignee
Cyberonics Inc
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,149,219 B2
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 9,155,843 B2
Filed 07/26/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Obstructive sleep apnea treatment devices, systems and methods | ||
Patent #
US 9,186,511 B2
Filed 02/11/2014
|
Current Assignee
LivaNova USA Inc.
|
Original Assignee
Cyberonics Inc
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,192,328 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Devices and methods for sleep apnea treatment | ||
Patent #
US 9,205,262 B2
Filed 10/02/2012
|
Current Assignee
LivaNova USA Inc.
|
Original Assignee
Cyberonics Inc
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 9,220,449 B2
Filed 07/09/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Neurostimulation system for preventing magnetically induced currents in electronic circuitry | ||
Patent #
US 9,220,901 B2
Filed 03/13/2013
|
Current Assignee
Boston Scientific Neuromodulation Corporation
|
Original Assignee
Boston Scientific Neuromodulation Corporation
|
Self expanding electrode cuff | ||
Patent #
US 9,227,053 B2
Filed 05/01/2009
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Analyte sensor | ||
Patent #
US 9,247,900 B2
Filed 06/04/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,247,901 B2
Filed 08/02/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Hypertension therapy implant apparatus | ||
Patent #
US 9,248,291 B2
Filed 10/23/2014
|
Current Assignee
Man Science S.A.
|
Original Assignee
Adi Mashiach
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,282,925 B2
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Devices and methods for delivering energy as a function of condition severity | ||
Patent #
US 9,302,093 B2
Filed 09/28/2012
|
Current Assignee
Nyxoah SA
|
Original Assignee
Nyxoah SA
|
Apparatus and methods for modulating nerves using parallel electric fields | ||
Patent #
US 9,314,613 B2
Filed 09/28/2012
|
Current Assignee
Man Science S.A.
|
Original Assignee
Adi Mashiach
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 9,314,196 B2
Filed 09/07/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
DEVICE FOR DETECTING ELECTRIC POTENTIALS | ||
Patent #
US 20160113532A1
Filed 10/27/2015
|
Current Assignee
Draegerwerk AG Co KGaA
|
Original Assignee
Dragerwerk AG Company KGaA
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,716 B2
Filed 12/05/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,714 B2
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,351,668 B2
Filed 10/12/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Electrode configuration for implantable modulator | ||
Patent #
US 9,358,392 B2
Filed 01/05/2015
|
Current Assignee
Man Science S.A.
|
Original Assignee
Adi Mashiach
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,364,173 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Shaped coils for transcranial magnetic stimulation | ||
Patent #
US 9,381,374 B2
Filed 09/14/2015
|
Current Assignee
Brainsway Ltd.
|
Original Assignee
Rio Grande Neurosciences Inc.
|
Method and apparatus for controlling a neural stimulus | ||
Patent #
US 9,381,356 B2
Filed 05/11/2012
|
Current Assignee
Saluda Medical Pty Ltd.
|
Original Assignee
Saluda Medical Pty Ltd.
|
APPARATUS FOR MONITORING OPTICAL SIGNAL | ||
Patent #
US 20160216446A1
Filed 01/25/2016
|
Current Assignee
Electronics and Telecommunications Research Institute
|
Original Assignee
Electronics and Telecommunications Research Institute
|
Apparatus and methods for implant coupling indication | ||
Patent #
US 9,403,009 B2
Filed 09/28/2012
|
Current Assignee
Nyxoah SA
|
Original Assignee
Nyxoah SA
|
Method for controlling energy delivery as a function of degree of coupling | ||
Patent #
US 9,409,013 B2
Filed 09/30/2013
|
Current Assignee
Nyxoah SA
|
Original Assignee
Nyxoah SA
|
Transcutaneous analyte sensor | ||
Patent #
US 9,414,777 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods for treatment of sleep apnea | ||
Patent #
US 9,415,215 B2
Filed 10/16/2015
|
Current Assignee
Nyxoah SA
|
Original Assignee
Nyxoah SA
|
Devices for treatment of sleep apnea | ||
Patent #
US 9,415,216 B2
Filed 10/16/2015
|
Current Assignee
Nyxoah SA
|
Original Assignee
Nyxoah SA
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,420,968 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Head pain management device having an antenna | ||
Patent #
US 9,421,372 B2
Filed 10/23/2014
|
Current Assignee
Man Science S.A.
|
Original Assignee
Carsten Mueller, Adi Mashiach
|
Methods and systems for promoting glucose management | ||
Patent #
US 9,446,194 B2
Filed 03/26/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 9,451,908 B2
Filed 12/19/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Trajectory-based deep-brain stereotactic transcranial magnetic stimulation | ||
Patent #
US 9,486,639 B2
Filed 09/22/2011
|
Current Assignee
US Department of Veterans Affairs
|
Original Assignee
Board of Trustees of the Leland Stanford Junior University
|
Functional electrical stimulus unit | ||
Patent #
US 9,486,627 B1
Filed 10/30/2009
|
Current Assignee
Carter B. White
|
Original Assignee
Carter B. White
|
Percutaneous access for systems and methods of treating sleep apnea | ||
Patent #
US 9,486,628 B2
Filed 03/30/2010
|
Current Assignee
Inspire Medical Systems Inc.
|
Original Assignee
Inspire Medical Systems Inc.
|
Transcranial magnetic stimulation for altering susceptibility of tissue to pharmaceuticals and radiation | ||
Patent #
US 9,492,679 B2
Filed 07/15/2011
|
Current Assignee
Brainsway Ltd.
|
Original Assignee
Rio Grande Neurosciences Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,498,159 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,498,155 B2
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,510,782 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Multichannel clip device and methods of use | ||
Patent #
US 9,517,338 B1
Filed 01/19/2016
|
Current Assignee
Axonics Modulation Technologies Inc.
|
Original Assignee
Axonics Modulation Technologies Inc.
|
Posture sensor automatic calibration | ||
Patent #
US 9,523,706 B2
Filed 07/18/2013
|
Current Assignee
Cardiac Pacemakers Incorporated
|
Original Assignee
Cardiac Pacemakers Incorporated
|
Apparatus and methods for feedback-based nerve modulation | ||
Patent #
US 9,550,064 B2
Filed 01/11/2016
|
Current Assignee
Man Science S.A.
|
Original Assignee
Adi Mashiach
|
Screening devices and methods for obstructive sleep apnea therapy | ||
Patent #
US 9,555,247 B2
Filed 07/20/2015
|
Current Assignee
LivaNova USA Inc.
|
Original Assignee
Cyberonics Inc
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,585,607 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,603,557 B2
Filed 05/13/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,610,034 B2
Filed 11/09/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,610,031 B2
Filed 04/13/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and method for neuro-stimulation | ||
Patent #
US 9,616,234 B2
Filed 04/10/2014
|
Current Assignee
Afferent Corporation
|
Original Assignee
Trustees of Boston University
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,649,069 B2
Filed 06/29/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and method for nerve modulation using noncontacting electrodes | ||
Patent #
US 9,649,493 B2
Filed 09/30/2013
|
Current Assignee
Man Science S.A.
|
Original Assignee
Adi Mashiach
|
Analyte sensor | ||
Patent #
US 9,668,677 B2
Filed 10/26/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
POWER MANAGEMENT IN TRANSCRANIAL MAGNETIC STIMULATORS | ||
Patent #
US 20170203116A1
Filed 08/26/2016
|
Current Assignee
Brainsway Ltd.
|
Original Assignee
John W. Sadler
|
MULTICHANNEL CLIP DEVICE AND METHODS OF USE | ||
Patent #
US 20170203098A1
Filed 01/19/2016
|
Current Assignee
Axonics Modulation Technologies Inc.
|
Original Assignee
Axonics Modulation Technologies Inc.
|
Systems and methods for processing sensor data | ||
Patent #
US 9,717,449 B2
Filed 01/15/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,724,045 B1
Filed 04/06/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated medicament delivery device for use with continuous analyte sensor | ||
Patent #
US 9,741,139 B2
Filed 08/09/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Obstructive sleep apnea treatment devices, systems and methods | ||
Patent #
US 9,744,354 B2
Filed 12/30/2009
|
Current Assignee
Cyberonics Inc
|
Original Assignee
Cyberonics Inc
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,750,441 B2
Filed 08/15/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,750,460 B2
Filed 04/14/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Devices and methods for sleep apnea treatment | ||
Patent #
US 9,757,564 B2
Filed 11/10/2015
|
Current Assignee
LivaNova USA Inc.
|
Original Assignee
Cyberonics Inc
|
Medical device communication and charging assemblies for use with implantable signal generators, and associated systems and methods | ||
Patent #
US 9,776,002 B2
Filed 12/22/2014
|
Current Assignee
Nevro Corporation
|
Original Assignee
Nevro Corporation
|
Transcutaneous analyte sensor | ||
Patent #
US 9,801,572 B2
Filed 06/18/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,814,414 B2
Filed 03/30/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,833,143 B2
Filed 06/05/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,833,176 B2
Filed 07/12/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and apparatus for application of a neural stimulus | ||
Patent #
US 9,872,990 B2
Filed 09/03/2015
|
Current Assignee
National ICT Australia Limited
|
Original Assignee
Saluda Medical Pty Ltd.
|
Hypertension therapy implant apparatus | ||
Patent #
US 9,878,159 B2
Filed 01/11/2016
|
Current Assignee
Man Science S.A.
|
Original Assignee
Adi Mashiach
|
Transvenous method of treating sleep apnea | ||
Patent #
US 9,889,299 B2
Filed 09/30/2009
|
Current Assignee
Inspire Medical Systems Inc.
|
Original Assignee
Inspire Medical Systems Inc.
|
System and methods for processing analyte sensor data | ||
Patent #
US 9,895,089 B2
Filed 05/20/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Devices and methods for low current neural modulation | ||
Patent #
US 9,895,540 B2
Filed 02/21/2014
|
Current Assignee
Man Science S.A.
|
Original Assignee
Nyxoah SA
|
MEDICAL DEVICE COMMUNICATION AND CHARGING ASSEMBLIES FOR USE WITH IMPLANTABLE SIGNAL GENERATORS, AND ASSOCIATED SYSTEMS AND METHODS | ||
Patent #
US 20180064945A1
Filed 09/15/2017
|
Current Assignee
Nevro Corporation
|
Original Assignee
Nevro Corporation
|
Obstructive sleep apnea treatment devices, systems and methods | ||
Patent #
US 9,913,982 B2
Filed 05/12/2011
|
Current Assignee
LivaNova USA Inc.
|
Original Assignee
Cyberonics Inc
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 9,918,668 B2
Filed 03/09/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and device for treating sleep apnea based on tongue movement | ||
Patent #
US 9,943,686 B2
Filed 08/08/2016
|
Current Assignee
Nyxoah SA
|
Original Assignee
Nyxoah SA
|
Device for detecting electric potentials | ||
Patent #
US 9,968,272 B2
Filed 10/27/2015
|
Current Assignee
Draegerwerk AG Co KGaA
|
Original Assignee
Dragerwerk AG Company KGaA
|
Method and apparatus for estimating neural recruitment | ||
Patent #
US 9,974,455 B2
Filed 05/11/2012
|
Current Assignee
Saluda Medical Pty Ltd.
|
Original Assignee
Saluda Medical Pty Ltd.
|
Analyte sensor | ||
Patent #
US 9,986,942 B2
Filed 08/10/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,022,078 B2
Filed 05/23/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Devices and methods for sleep apnea treatment | ||
Patent #
US 10,052,484 B2
Filed 09/11/2017
|
Current Assignee
LivaNova USA Inc.
|
Original Assignee
Cyberonics Inc
|
Simultaneous physiological sensing and stimulation with saturation detection | ||
Patent #
US 10,080,898 B2
Filed 05/29/2015
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Obstructive sleep apnea treatment devices, systems and methods | ||
Patent #
US 10,105,538 B2
Filed 12/29/2010
|
Current Assignee
Cyberonics Inc
|
Original Assignee
Cyberonics Inc
|
Systems and methods for processing sensor data | ||
Patent #
US 10,182,751 B2
Filed 06/26/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Multichannel clip device and methods of use | ||
Patent #
US 10,195,423 B2
Filed 01/19/2016
|
Current Assignee
Axonics Modulation Technologies Inc.
|
Original Assignee
Axonics Modulation Technologies Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,201,301 B2
Filed 04/18/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for controlling electrical conditions of tissue | ||
Patent #
US 10,206,596 B2
Filed 11/06/2013
|
Current Assignee
National ICT Australia Limited
|
Original Assignee
Saluda Medical Pty Ltd.
|
Screening devices and methods for obstructive sleep apnea therapy | ||
Patent #
US 10,231,645 B2
Filed 01/27/2017
|
Current Assignee
LivaNova USA Inc.
|
Original Assignee
LivaNova USA Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,231,654 B2
Filed 06/23/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for measurement of neural response | ||
Patent #
US 10,278,600 B2
Filed 06/16/2016
|
Current Assignee
Saluda Medical Pty Ltd.
|
Original Assignee
Saluda Medical Pty Ltd.
|
Nerve cuff | ||
Patent #
US 10,286,206 B2
Filed 01/13/2015
|
Current Assignee
Inspire Medical Systems Inc.
|
Original Assignee
Inspire Medical Systems Inc.
|
Analyte sensor | ||
Patent #
US 10,314,525 B2
Filed 01/06/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 10,327,638 B2
Filed 10/30/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,349,873 B2
Filed 04/27/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Neural measurement | ||
Patent #
US 10,368,762 B2
Filed 05/05/2015
|
Current Assignee
Saluda Medical Pty Ltd.
|
Original Assignee
Saluda Medical Pty Ltd.
|
Integrated medicament delivery device for use with continuous analyte sensor | ||
Patent #
US 10,403,012 B2
Filed 07/18/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and device for detecting a neural response in a neural measurement | ||
Patent #
US 10,426,409 B2
Filed 11/22/2014
|
Current Assignee
Saluda Medical Pty Ltd.
|
Original Assignee
Saluda Medical Pty Ltd.
|
Impedance matching and electrode conditioning in patient interface systems | ||
Patent #
US 10,434,308 B2
Filed 05/29/2015
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Stair ascent and descent control for powered lower limb devices | ||
Patent #
US 10,441,439 B2
Filed 03/15/2013
|
Current Assignee
Vanderbilt University
|
Original Assignee
Vanderbilt University
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,478,108 B2
Filed 02/05/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Electrical stimulation cuff devices and systems | ||
Patent #
US 10,485,969 B2
Filed 02/17/2017
|
Current Assignee
Boston Scientific Neuromodulation Corporation
|
Original Assignee
Boston Scientific Neuromodulation Corporation
|
Leads for electrostimulation of peripheral nerves and other targets | ||
Patent #
US 10,493,269 B2
Filed 05/30/2017
|
Current Assignee
Boston Scientific Neuromodulation Corporation
|
Original Assignee
Boston Scientific Neuromodulation Corporation
|
Method and device for feedback control of neural stimulation | ||
Patent #
US 10,500,399 B2
Filed 12/11/2015
|
Current Assignee
Saluda Medical Pty Ltd.
|
Original Assignee
Saluda Medical Pty Ltd.
|
Transcutaneous analyte sensor | ||
Patent #
US 10,524,703 B2
Filed 01/24/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and systems for promoting glucose management | ||
Patent #
US 10,537,678 B2
Filed 12/16/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Percutaneous access for systems and methods of treating sleep-related disordered breathing | ||
Patent #
US 10,543,366 B2
Filed 11/07/2016
|
Current Assignee
Inspire Medical Systems Inc.
|
Original Assignee
Inspire Medical Systems Inc.
|
Method and apparatus for measurement of neural response | ||
Patent #
US 10,568,559 B2
Filed 05/11/2012
|
Current Assignee
Saluda Medical Pty Ltd.
|
Original Assignee
Saluda Medical Pty Ltd.
|
Method and system for applying stimulation in treating sleep disordered breathing | ||
Patent #
US 10,583,297 B2
Filed 01/09/2018
|
Current Assignee
Inspire Medical Systems Inc.
|
Original Assignee
Inspire Medical Systems Inc.
|
Method and apparatus for measurement of neural response | ||
Patent #
US 10,588,524 B2
Filed 05/11/2012
|
Current Assignee
Saluda Medical Pty Ltd.
|
Original Assignee
Saluda Medical Pty Ltd.
|
Implantable electrode positioning | ||
Patent #
US 10,588,698 B2
Filed 11/30/2015
|
Current Assignee
Saluda Medical Pty Ltd.
|
Original Assignee
Saluda Medical Pty Ltd.
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,610,137 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,610,136 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,610,135 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and systems for promoting glucose management | ||
Patent #
US 10,610,642 B2
Filed 12/30/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,617,336 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Neural stimulation dosing | ||
Patent #
US 10,632,307 B2
Filed 07/27/2015
|
Current Assignee
Saluda Medical Pty Ltd.
|
Original Assignee
Saluda Medical Pty Ltd.
|
Obstructive sleep apnea treatment devices, systems and methods | ||
Patent #
US 10,632,308 B2
Filed 07/31/2017
|
Current Assignee
LivaNova USA Inc.
|
Original Assignee
LivaNova USA Inc.
|
Obstructive sleep apnea treatment devices, systems and methods | ||
Patent #
US 10,632,306 B2
Filed 08/25/2017
|
Current Assignee
LivaNova USA Inc.
|
Original Assignee
LivaNova USA Inc.
|
Integrated insulin delivery system with continuous glucose sensor | ||
Patent #
US 10,653,835 B2
Filed 10/24/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Obstructive sleep apnea treatment devices, systems and methods | ||
Patent #
US RE48,024 E1
Filed 04/08/2015
|
Current Assignee
LivaNova USA Inc.
|
Original Assignee
LivaNova USA Inc.
|
Obstructive sleep apnea treatment devices, systems and methods | ||
Patent #
US RE48,025 E1
Filed 04/22/2015
|
Current Assignee
LivaNova USA Inc.
|
Original Assignee
LivaNova USA Inc.
|
Methods and systems for simulating glucose response to simulated actions | ||
Patent #
US 10,675,405 B2
Filed 12/04/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,709,364 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,709,362 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,709,363 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for making and using an electrical stimulation system for peripheral nerve stimulation | ||
Patent #
US 10,709,888 B2
Filed 07/21/2017
|
Current Assignee
Boston Scientific Neuromodulation Corporation
|
Original Assignee
Boston Scientific Neuromodulation Corporation
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,716,498 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,722,152 B2
Filed 11/05/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Obstructive sleep apnea treatment devices, systems and methods | ||
Patent #
US 10,737,094 B2
Filed 10/18/2018
|
Current Assignee
LivaNova USA Inc.
|
Original Assignee
LivaNova USA Inc.
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,743,801 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 10,786,185 B2
Filed 01/05/2018
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,799,158 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,799,159 B2
Filed 02/13/2020
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Implantable electrical stimulator | ||
Patent #
US 10,806,926 B2
Filed 10/20/2009
|
Current Assignee
Man Science S.A.
|
Original Assignee
Man Science S.A.
|
Analyte sensor | ||
Patent #
US 10,813,577 B2
Filed 02/13/2020
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,813,576 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Slotted sleeve neurostimulation device | ||
Patent #
US 10,814,127 B2
Filed 02/03/2017
|
Current Assignee
Boston Scientific Neuromodulation Corporation
|
Original Assignee
Boston Scientific Neuromodulation Corporation
|
Devices and methods for low current neural modulation | ||
Patent #
US 10,828,492 B2
Filed 01/18/2018
|
Current Assignee
Nyxoah SA
|
Original Assignee
Adi Mashiach
|
Integrated insulin delivery system with continuous glucose sensor | ||
Patent #
US 10,835,672 B2
Filed 05/05/2020
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Monitoring brain neural activity | ||
Patent #
US 10,849,525 B2
Filed 05/31/2016
|
Current Assignee
Closed Loop Medical Pty. Ltd.
|
Original Assignee
Saluda Medical Pty Ltd.
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,856,787 B2
Filed 07/31/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Devices and methods for sleep apnea treatment | ||
Patent #
US 10,864,375 B2
Filed 08/13/2018
|
Current Assignee
LivaNova USA Inc.
|
Original Assignee
LivaNova USA Inc.
|
Electrode to nerve distance estimation | ||
Patent #
US 10,894,158 B2
Filed 04/08/2016
|
Current Assignee
Saluda Medical Pty Ltd.
|
Original Assignee
Saluda Medical Pty Ltd.
|
Implantable signal amplifying circuit for electroneurographic recording | ||
Patent #
US 6,996,435 B2
Filed 11/19/2001
|
Current Assignee
4491343 Canada Inc.
|
Original Assignee
Neurostream Technologies G.P.
|
Precision full-wave rectifier circuit for high-density, low-power implantable medical device | ||
Patent #
US 20040164783A1
Filed 02/24/2003
|
Current Assignee
Neurostream Technologies G.P.
|
Original Assignee
Neurostream Technologies G.P.
|
Method and implantable systems for neural sensing and nerve stimulation | ||
Patent #
US 20030144710A1
Filed 11/15/2002
|
Current Assignee
Neurodan AS
|
Original Assignee
Neurodan AS
|
NEURAL PROSTHESIS | ||
Patent #
US 20020055779A1
Filed 03/05/1997
|
Current Assignee
The Governors of the University of Alberta
|
Original Assignee
The Governors of the University of Alberta
|
Implantable medical device incorporating adiabatic clock-powered logic | ||
Patent #
US 6,415,181 B1
Filed 02/25/2000
|
Current Assignee
Medtronic Incorporated
|
Original Assignee
Medtronic Incorporated
|
Systems and methods for performing prosthetic or therapeutic neuromuscular stimulation using a universal external controller accommodating different control inputs and/or different control outputs | ||
Patent #
US 20020188331A1
Filed 03/30/2001
|
Current Assignee
Neurocontrol Corporation
|
Original Assignee
Neurocontrol Corporation
|
Multi-electrode neurological stimulation apparatus | ||
Patent #
US 5,038,781 A
Filed 04/19/1990
|
Current Assignee
Hassan Hamedi
|
Original Assignee
Hassan Hamedi
|
Closed-loop, implanted-sensor, functional electrical stimulation system for partial restoration of motor functions | ||
Patent #
US 4,750,499 A
Filed 08/20/1986
|
Current Assignee
Joaquin A. Hoffer
|
Original Assignee
Joaquin A. Hoffer
|
37 Claims
-
1. A totally implantable nerve stimulation system, comprising:
-
one or more nerve cuffs having electrodes therein that contact a nerve or nerves;
an event-triggered, closed-loop control unit that is connected to receive signals from at least one electrode in a nerve cuff and to deliver stimulation pulses to at least one electrode in order to produce a desired physiological response, the closed-loop control unit including;
an internal electrical power source;
a processor;
a number of signal conditioning circuits;
a programmable switch controlled by the processor to connect an electrode to a signal conditioning circuit;
at least one stimulation circuit that delivers a stimulation pulse to one or more of the electrodes;
wherein the processor selectively enables the number of signal conditioning circuits, the programmable switch and the at least one stimulation circuit to lengthen the life of the electrical power source. - View Dependent Claims (2, 3, 4, 5, 6, 7)
-
-
8. A fully implantable nerve stimulation system for treating foot drop, comprising:
-
one or more nerve cuffs having electrodes therein that detect signals from and/or deliver stimulation pulses to a nerve fiber;
a sealed closed-loop control unit that is implantable in a patient, the closed-loop control unit including;
an electrical power source;
a processor;
one or more signal conditioning circuits that are selectively coupled to an electrode in a nerve cuff; and
one or more stimulation circuits that deliver stimulation pulses to an electrode;
wherein the processor detects the occurrence of a heel contact or toe lift event by filtering the output signals produced by the one or more signal conditioning circuits.
-
-
9. A fully implantable nerve stimulation system for treating foot drop, comprising:
-
one or more nerve cuffs having electrodes therein that detect signals from and/or deliver stimulation pulses to a nerve;
a sealed closed-loop control unit that is implantable in a patient, the closed-loop control unit including;
an electrical power source;
a processor;
one or more signal conditioning circuits that are selectively coupled to an electrode in a nerve cuff; and
one or more stimulation circuits that deliver stimulation pulses to an electrode;
wherein the processor detects the occurrence of a heel contact or toe lift event by filtering the output signals produced by the one or more signal conditioning circuits and comparing the filtered output signals with the unfiltered output signals to detect a rising or falling ramp in the output signals and wherein the processor causes at least one stimulation pulse to be delivered to an electrode upon detection of a toe lift event. - View Dependent Claims (10, 11, 12, 13, 14, 15, 16, 17, 18)
-
-
19. An implantable system for treating foot drop comprising:
-
a control unit that is implanted in the body, the control unit including;
an electrical power source;
a processor;
at least one signal conditioning circuit;
at least one nerve stimulation circuit; and
at least one nerve cuff having electrodes therein that detect signals from and/or deliver a stimulation pulse to a nerve fiber;
wherein the processor in the control unit detects physiological event signals from the processed nerve signals produced by the at least one signal conditioning circuit and delivers a stimulation pulse to an electrode upon detection of a physiological event. - View Dependent Claims (20, 21, 22, 23, 24)
-
-
25. An implantable circuit for correcting foot drop comprising:
-
one or more nerve cuffs including a number of electrodes to be placed around a nerve for sensing nerve signals and/or for delivering stimulation pulses to a nerve;
an implantable event driven control unit including;
a source of electrical power;
a processor;
a sensor for producing a signal indicative of an angle of a patient'"'"'s thigh;
a number of signal conditioning circuits that are selectively connectable under control of the processor to one or more electrodes to process nerve signals;
at least one nerve stimulation circuit that is selectively connectable to an electrode to deliver a stimulation pulse to the nerve;
wherein the processor is programmed to operate in a plurality of modes that are dependent in part on the sensed angle of the patient'"'"'s thigh. - View Dependent Claims (26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36)
-
-
37. An implantable circuit for delivering stimulation signals to a patient'"'"'s muscle, comprising:
-
one or more nerve cuffs including a number of electrodes to be placed around a nerve for sensing nerve signals and/or for delivering stimulation pulses to a nerve;
an implantable event driven control unit including;
a source of electrical power;
a processor;
a number of signal conditioning circuits that are selectively connectable-under control of the processor to an electrode to process nerve signals;
at least one nerve stimulation circuit that is selectively connectable to an electrode to deliver a stimulation pulse to the nerve;
wherein the processor is programmed to operate in a user initiated exercise mode such that stimulation signals are delivered to a nerve signal for a period of time to exercise the patient'"'"'s muscle.
-
1 Specification
The present application claims the benefit of U.S. Provisional Application No. 60/460,275, filed Apr. 2, 2003, which is herein incorporated by reference.
The present invention relates to medical devices in general and to nerve stimulation devices in particular.
Foot drop is a severely disabling condition that commonly occurs as a consequence of a cerebral vascular accident or central neurological lesion in the cortex, brain stem and/or spinal cord, such as can occur with stroke, multiple sclerosis, brain cancer, traumatic brain injury, incomplete spinal cord injury, or cerebral palsy. The resulting paralysis or paresis in the ankle dorsiflexor muscles prevents a person from lifting the affected foot such that the foot is dragged and the toes stumble during walking. When the cause of the foot drop is a central neurological lesion, the ankle dorsiflexor musculature and the peripheral innervation via the common peroneal nerve are physiologically intact. However, as a consequence of the paralysis or paresis, a complex pathological sequelae develops that includes ankle extensor muscle spasticity, clonus and hyperextension, weakness in hip and knee flexor muscles, marked atrophy in the ankle dorsiflexor muscles due to disuse, compensatory gait and posture abnormalities that include hip circumduction and knee hyperextension, and pain and chronic joint problems frequently result from gait and posture abnormalities.
The foot drop disability commonly results in several impairments in gait, such as asymmetries, poor weight support in the affected leg, slow and laborious walking, impairments in posture and balance, as well as reduced endurance, rapid fatigue and high metabolic cost of walking. The foot drop condition interferes with activities of daily living such as mobility and independence and increase morbidity through increased risk of falls and hip fracture.
Until now, people suffering from foot drop have been treated primarily with ankle-foot orthoses, which are braces that clamp the ankle joint at a set angle, allowing limited or no mobility. This helps the foot drop patient when walking, since the toes no longer stumble. However, the treatment has numerous problems. The sustained pressure applied to the leg and the skin below the knee can cause pain, skin breakdown, and even peroneal nerve palsy. Use of a brace also reinforces the process of progressive atrophy of the disused dorsiflexor muscles and the onset of osteoporosis. The brace must be donned and doffed and may not be cosmetically acceptable, especially by children.
A more advanced approach for treating foot drop involves the application of electrical stimulation (ES), also known as functional electrical stimulation (FES) or functional neuromuscular stimulation (FNS) to the peroneal nerve in order to electrically activate the paralyzed or paretic muscles at appropriate times to lift the foot during walking.
Currently available, the FES systems for treating foot drop have been either totally external to the body or partially implanted with certain components implanted and other components external to the body. The totally external stimulation systems typically consist of stimulation electrodes that are placed on the skin over the area below the knee where the common peroneal nerve courses quite superficially, as well as a battery power source, a sensor (typically either a foot contact electromechanical switch worn in or under the shoe, or an accelerometer-based movement sensor) and the stimulation control circuitry. Problems with totally external stimulation systems have included excessive foot eversion produced with a single channel of stimulation, difficulties with electrode placement, variable results because of electrode movement or changes to skin conductance, pain or discomfort caused by the skin stimulation as well as the requirement for daily donning and doffing. Frequent malfunctions and breakdowns of mechanical switches and external cables are also common. Furthermore, such systems are cosmetically poor.
Historically, the Neuromuscular Assist (NMA) developed in 1968-1977 by McNeal, Perry and Waters at Rancho Los Amigos Hospital, CA was the first partially implanted peroneal nerve stimulation system. It consisted of three parts: an external power source and RF transmitter, an implanted receiver connected to a bipolar electrode wrapped around the peroneal nerve, and a heel switch worn inside the shoe that initiated stimulation during the swing phase. This team implanted 16 patients between November 1971 and January 1974 and did a two-year follow-up study. Correction of foot drop was obtained in 13 of 16 subjects. Failures were due to infection, peroneal palsy, or discontinued use. Stimulation voltages were stable after six weeks and the conduction velocity of the peroneal nerve was normal throughout the duration of the study. Dorsiflexion torque (supramaximal stimulation) remained above immediate postoperative values. However, the NMA device proved not to be practical. One of the original developers of the NMA reported the following limitations with that device:
- Intact cognition and considerable patient motivation were required to wear and operate the equipment on a daily basis; and
- It was difficult to obtain balanced dorsiflexion with a single channel of stimulation.
Dr. Waters concluded in 1977 that broad acceptance of a foot drop correction system will require a totally implanted system and he also anticipated then that multi-channel peroneal stimulation will be necessary in order to obtain more balanced dorsiflexion. In the intervening time, numerous other FES-based foot drop systems have been developed but, prior to the present invention, no totally implanted foot drop correction device has been developed.
In partially implanted systems used to date, the implanted components typically include one or more stimulation electrodes, an implanted receiving antenna, and sometimes some stimulation circuitry. The external components generally include the power source, sensors, and circuitry or a computer to detect the occurrence of gait-related events in the sensed signal, as well as external antenna for communication and power transmission. Some partially implanted FES systems for treating foot drop use radio frequency telemetry communication for on-line control of the stimulation circuits by the external closed-loop control unit and sometimes also for communication between the external sensors and the external control circuitry. Problems with partially implanted FES systems for treating foot drop include: the need to don/doff the external components, crude on-off control, and the requirement that users must wear a shoe when the foot switches are used. Finally, currently available systems have been known to exhibit frequent breakdown of mechanical sensors or external connecting wires and problems with aligning the internal and external antenna for safe communication and operation.
More advanced, partially implanted systems under development are designed to detect a physiological signal that is gait-related and can be sensed by implanted nerve sensing electrodes, such as a nerve cuff electrode placed on a peripheral nerve supplying the foot sole, and such sensed nerve signal may be used as feedback signal to control a stimulation device, as was originally taught by Hoffer (1988). Strange and Hoffer (1999a, 1999b) implemented in the cat forelimb a real time FES state controller that was designed to sense natural sensory nerve signals using nerve cuff electrodes and use the sensed signals as feedback to control the timing of activation with FES of the Palmaris Longus muscle during walking on a treadmill. Thus, the principle of using sensory nerve signals as feedback to control FES of paralyzed or paretic muscles is well understood. However, until now it has been impossible to implement feedback from nerve signals in fully implanted, clinically applicable FES systems, because of the unavailability of suitable implantable circuitry to amplify and process the signals sensed from nerves and to reliably detect the needed gait-related event information from the sensed nerve signals.
However, a limitation in the ability to implement this approach until now has been the unavailability of suitable implantable circuitry to amplify and process the signals sensed from nerves and to reliably detect the gait-related events from the sensed nerve signals.
Given these problems and limitations of existing foot drop systems, there is a need for a low power, totally implantable, event-triggered, closed-loop electrical stimulation system for controlling foot drop or other disorders to restore appropriate movement to an impaired foot, leg or other body part as needed for walking, postural adjustments, or other normal activities for daily living.
To address the problems discussed above, the present invention is a totally implantable, event-triggered, closed-loop electrical stimulation system for selectively stimulating nerve fibers in order to produce a desired physiological response, such as alleviating foot drop.
The nerve stimulation system includes a battery-powered implantable sensing and electrical stimulation control unit and one or more nerve cuffs having a number of electrodes therein that detect signals from a nerve and deliver stimulation to a nerve. The closed-loop control unit includes a number of signal conditioning circuits that condition the nerve signals sensed by the electrodes. The processed nerve signals are provided to a low-power processor or microcontroller that executes an event detection algorithm to detect the occurrence of a physiological event from the signals. Detection of an event triggers the processor to cause one or more stimulation pulses to be applied to a nerve in order to elicit a desired physiological response. The processor is also programmed to monitor the position of a limb or body segment and shut down circuitry when the user is not standing in order to minimize battery power consumption and thus lengthen the expected life of the battery.
The foregoing aspects and many of the attendant advantages of this invention will become more readily appreciated as the same become better understood by reference to the following detailed description, when taken in conjunction with the accompanying drawings, wherein:
As indicated above, the present invention is a totally implantable system for selectively sensing gait-related events from sensory nerve signals and for electrically stimulating nerve fibers in order to produce a desired movement or physiological response. Although the disclosed embodiment is directed for alleviating foot drop, it will be appreciated that the invention could be used to alleviate other conditions, such as bladder incontinence, obstructive sleep apnea, phrenic nerve stimulation, control of prosthetic limbs, etc., by programming the device to detect different features from nerve signals sensed from a certain nerve and to stimulate the same or different nerve fibers.
As shown in
The closed-loop control unit 50 and nerve cuffs 54, 56 are preferably entirely implanted proximal to the patient'"'"'s knee so that the leads that connect the closed-loop control unit 50 to the nerve cuffs 54, 56 are as short as practicable and do not cross any joint in the patient. Such a placement minimizes the chance that the leads will fail due to repeated bending of the wires and insulation during movement of the leg, and also maximizes the mechanical stability of the nerve cuffs on the nerves. In the embodiment shown in
In some instances, it is possible to reliably detect both the heel contact (HC) and toe lift (TL) events from the same nerve that is used to stimulate the foot dorsiflexor muscles. In this case, the nerve stimulation system shown in
In other patients, the location of the branch point where the tibial nerve 58 and common peroneal nerve 60 separate from the sciatic nerve 62 occurs very distally within the thigh, making it difficult for a surgeon to place a nerve cuff around a nerve branch below the bifurcation. In such case, the embodiment shown in
In each of the embodiments shown in
A block diagram of an implantable nerve stimulation system in accordance with one embodiment of the present invention is shown in
The wireless transmitter/receiver 152 allows the processor 150 to communicate with an external controller (shown in
The magnet detector 154 detects the presence of an external magnet (shown in
The accelerometer circuit 156 provides signals from a pair of orthogonally oriented accelerometers that are used to determine the angle of the patient'"'"'s thigh. Signals from the accelerometer circuit 156 are used to determine if the patient is standing and what type of stimulation signals should be provided to the muscles depending upon whether the patient is walking on a level surface or up/down a set of stairs.
A long life battery, such as a lithium battery 160, provides power to the processor 150 and other peripherals of the closed-loop nerve stimulation system. The battery 160 is connected to the battery monitoring circuit 158 that provides the processor 150 with a signal that is indicative of the expected life of the battery 160. The closed-loop control unit 50 also includes a low voltage power supply 170 and a high voltage power supply 172. The low voltage power supply 170 supplies power to the processors 150, to a bank of amplifiers and signal conditioning circuits 180 that amplify and condition the nerve signals sensed by the electrodes in a nerve cuff, as well as to a voltage reference circuit 174. The high voltage power supply 172 supplies power to a bank of stimulation circuits 184 that deliver stimulation pulses to the electrodes in the nerve cuffs.
There are N signal conditioning circuits of which one or more are selected to detect the HC and TL events. The number of signal conditioning circuits used and which electrodes they are connected to are programmable by the doctor or the physical therapist.
The external programmer 220 and a user interface 226 are used by a physician or physical therapist to tune the operation of the implanted closed-loop nerve stimulation system. The wireless receiver/transmitter 210 is coupled to the external programmer 220 and user interface 226 residing in a battery powered laptop or other computer, such as a personal digital assistant (PDA), in order to allow a physician or physical therapist to program the closed-loop nerve stimulation system after it has been implanted inside the patient. The external programmer 220 can vary a number of programmable parameters including how many signal conditioning circuits are used to detect event signals from the nerve fibers and which electrodes each of the selected signal conditioning circuits is connected to. Similarly, which electrodes should receive the stimulation pulses and the pattern of stimulation can be adjusted to better control movement of the foot during the swing phase of walking by the patient.
A magnet 230 can be placed on the patient'"'"'s skin in the vicinity of the implanted closed-loop control unit 50 to trigger the magnet detector 154 in order to change the operation of the processor 150. The magnet detector 154 preferably comprises a reed switch or other magnetically activated component that detects the proximity of the magnet 230.
As will be explained in further detail below, the closed-loop control unit 50 is designed to operate with very low power consumption such that for the embodiment in
In some instances, it may be desirable to power the implantable closed-loop nerve stimulation system with a rechargeable, or secondary, battery. In the embodiment shown in
On the outside of the body, the external inductive energy transfer module 260 is positioned adjacent to the power link receiving antenna 259 that is inside the body. The electromagnetic energy delivered by the inductive energy transfer module 260 is received from an external charging circuit 262 which in turn is powered by a rechargeable battery pack 264. Therefore, the user can recharge the battery of the implanted closed-loop nerve stimulation system at any convenient time and location.
Each of the amplifiers Ai within the signal conditioning circuits 180 are micro-volt-level differential amplifiers with MOSFET input stages. Together with the sensing reference voltage 174 and the protection circuit 198, the amplifiers are described in U.S. patent application Ser. No. 09/988,112, titled Implantable Signal Amplifying Circuit for Electroneurographic Recording, filed Nov. 19, 2001, which is herein incorporated in its entirety by reference, but is summarized below for completeness. Each amplifier includes an extremely low DC input current MOSFET stage that serves as a first input protection circuit to limit current flow through the nerve and electrode wires. Protection circuit 198, which preferably comprises a parallel resistor/capacitor combination, provides a second input protection, in compliance with regulatory requirements, and serves to protect all amplifiers in case of any amplifier Ai failure. Such protection circuit 198 does not degrade the high CMRR needed in the signal conditioning circuit 180 and reduces the implant area. Also, the extremely low DC input currents of the MOSFET stages enable recording in between stimuli using the same nerve cuff electrode that delivers the stimulation.
To be used for closed-loop control, the amplifiers Ai in the bank of signal conditioning circuits 180 can be selected and programmed by the therapist using the external programmer 220 of
The signal conditioning circuits 180 and all power-ripple sensitive circuitry of closed-loop control unit 50, are powered by the low voltage power supply 170. The cascade of a low-input voltage, step-up DC/DC converter, and an ultra low-dropout regulator comprises the low voltage power supply 170. The processor 150 also controls the enabling of the low voltage power supply 170, further reducing power consumption.
Multi-channel cyclic stimulation of two or more electrodes in a nerve cuff is achieved by the programmable current reference 190 that is shared by all stimulation circuits. The stimulation circuits also include the low-on resistance, high-voltage switches 184, DC current blocking capacitors C1a and C1b, and the high voltage power supply 172. The number of stimulation channels, stimulation currents and patterns (i.e. initial doublet or triplet, ramps, etc.) are also selectable and programmable by the therapist. The stimulation waveform applied to a nerve is preferably a rectangular pulse, with programmable width, and exponential charge recovery. The delay between the end of the stimulation pulse and the start of the recovery discharge is preferably less than 100 μs.
For nerve stimulation, each of the switches 184 in the stimulation circuits connects the series combination of a first DC current-blocking capacitor C1a, the electrode-nerve impedance of the selected channel, and a second DC current-blocking capacitor C1b. The double capacitor scheme provides redundancy against single failure. To deliver the stimulus, the high voltage power supply 172 is connected to the free terminal of the first capacitor C1a, whereas the terminal of the programmable current reference 190 is connected to the free terminal of the second capacitor C1b. Charge recovery is performed by short-circuiting the terminals of the first and second capacitor. The switches 184 also perform this action at times that are controlled by the processor 150.
The programmable current reference 190 is also used for impedance measurements. When this measurement is requested by the therapist via the external programmer 220, the processor 150 sends two or more sub-threshold stimulation pulses and measures the voltage drop between the high voltage power supply 172 and the terminal of the programmable current reference 190 for each-pulse. These values are then sent back to the external programmer 220, where the complex impedance is automatically calculated using the measured values. This method of measuring impedance gives equivalent results to and avoids the need for a sinusoidal signal generator inside closed-loop control unit 50, which is traditionally used for nerve cuff electrode impedance measurements.
A programmable, low-input voltage, step-up DC/DC converter, composes the high voltage power supply 172. Its output voltage can be selected and programmed based on the stimulation current value needed for muscle recruitment and the measured impedance of the electrode-nerve interface. This feature allows reduction of power consumption during stimulation.
The processor 150 can also execute a therapist-programmable, therapeutic stimulation exercise program, which can be activated/deactivated by the patient using the external magnet 230 (see
The closed-loop control unit 50 has two states of operation: OFF and ON. While the control unit 50 is in the OFF State, it only attempts to communicate with the external programmer 220 once every second. The OFF state is the default state. The ON state, on the other hand, is further divided into SLEEP, READY, WALKING, STAIR-ASCENT, STAIR-DESCENT, and MAGNET OFF/EXERCISE modes. As a safety feature, the control unit 50 switches to the OFF state from any other mode if the battery voltage read by the battery monitoring circuit 158 is lower than a certain pre-defined value. Only interrogation and programming orders are executable in OFF State.
While the closed-loop control unit 50 is operating in the ON state, it automatically switches among the various operating modes depending on the sensed signals used for closed-loop control. These signals are the thigh angle measured by the accelerometer 156, the foot contact events detected by the processor 150 and the bank of signal conditioning circuits 180, and the presence of a magnet 230 as detected by the magnet detection circuit 154. For example, the closed-loop control unit 50 switches to SLEEP mode whenever the accelerometer module 156 indicates that the patient'"'"'s thigh is not vertical. In SLEEP mode, the processor 150 turns off most of the closed-loop control unit'"'"'s circuitry, thus minimising power consumption.
Upon detection that the thigh position is becoming vertical by the accelerometer circuit 156, the processor 150 “wakes up” and enters the READY mode to begin looking for physiological events, such as a toe lift (TL) event. Each signal conditioning circuit 180 is selectively coupled to an electrode in a nerve cuff by a programmable switch to scan for nerve signals indicating these events. Upon detection of one or both of these events, the processor 150 selectively enables one or more of the stimulation circuits by closing one or more switches 184 to deliver stimulation pulse(s) to the nerve fiber in order to move a muscle at the correct time in the patient'"'"'s step.
In SLEEP mode all stimulation and sensing circuits are disabled. The closed-loop control unit 50 checks the magnet presence every second and the thigh angle every two seconds. If the magnet is detected for more than 10 seconds, the closed-loop control it switches to OFF (Magnet OFF mode). It switches to READY mode when the thigh angle is vertical.
In EXERCISE mode the control unit stimulates with the programmed exercise pattern for 10 minutes or until the magnet is applied.
In READY mode the closed-loop control unit checks the thigh angle and switches back to SLEEP mode if it is not vertical. The sensing circuits are activated and the signal from the selected nerve to detect a TL event is sensed and processed using the event detection algorithm described. If a TL event is sensed it switches to WALKING mode SWING PHASE. If more than two consecutive TL events are sensed the device switches to STAIR DESCENT mode TRANSFER PHASE.
In WALKING mode SWING PHASE, the closed-loop control unit 50 stimulates according to the stimulation pattern programmed for walking on level ground. The sensing circuits are activated and the signal from the selected nerve to detect an HC event is sensed and processed using the event detection algorithm described. If an HC event is detected, the closed-loop control unit switches to WALKING mode STANCE PHASE. If no HC event is detected, it switches back to READY mode when the programmed time-out elapses. If the thigh angle corresponds to the programmed stair ascent angle, it will switch to STAIR ASCENT mode SUPPORT PHASE when a TL event is detected or the programmed time-out elapses.
In WALKING mode STANCE PHASE, the stimulation is turned off and the TL counter is reset. If a TL event is detected it switches to WALKING mode SWING PHASE. If a TL event is not detected and the programmed time-out elapses it switches to READY mode.
In STAIR DESCENT mode TRANSFER PHASE, the closed-loop control unit stimulates according to the stimulation pattern programmed for walking down stairs. Both signals from the selected nerves to detected HC and TL events are sensed and processed. If an HC event is detected the closed-loop control unit switches to WALKING mode STANCE PHASE. If a TL event is detected it switches to STAIR DESCENT mode SUPPORT PHASE. If no HC or TL events are detected and the programmed time-out elapses the closed-loop control unit turns off the stimulation and switches to READY mode.
In STAIR DESCENT mode SUPPORT PHASE, the stimulation is turned OFF. The sensing circuits are activated and the signal from the selected nerve to detect TL is sensed and processed. If a TL event is detected the closed-loop control un it switches to STAIR DESCENT mode TRANSFER PHASE. If no TL event is detected and the programmed time-out elapses, it switches to READY mode.
In STAIR ASCENT mode SUPPORT PHASE, the stimulation is turned OFF. The sensing circuits are activated and the signal from the selected nerve to detected TL is sensed and processed. If a TL event is detected and the thigh angle corresponds to the programmed stair ascent angle, the closed-loop control unit remains in the same state. If a TL event is detected and the thigh angle does not correspond to the programmed stair ascent angle, it switches to STAIR ASCENT mode TRANSFER PHASE. If no TL is detected and the programmed time-out elapses it switches to READY mode.
In STAIR ASCENT mode TRANSFER PHASE the closed-loop control unit stimulates according to the stimulation pattern programmed for walking up stairs. Both signals from the selected nerves to detect HC and TL events are sensed and processed. If an HC event is detected, the closed-loop control unit switches to WALKING mode STANCE PHASE. If a TL event is detected and the thigh angle does not correspond to the programmed stair ascent angle, the closed-loop control unit remains in the same state. If a TL event is detected and the thigh angle corresponds'"'"' to the programmed stair ascent angle it switches to STAIR ASCENT SUPPORT PHASE. If no HC or TL events are detected and the programmed time-out elapses, the closed-loop control unit turns off the stimulation and switches to READY mode.
At 306, the processor determines if the thigh is oriented in a vertical direction by checking the signals from the accelerometer circuit. If so, the device enters the READY mode 308. In the READY mode, the processor begins checking the angular orientation of the thigh at more frequent intervals such as every 50 milliseconds. If the thigh is vertical, the processor checks for the presence of a toe lift event at 312. If no toe lift is detected, processor returns to the READY mode 308. If the toe lift is detected, it is determined if the toe lift time is greater than 2 seconds at 314. If so, the processor enters the STAIR DESCENT TRANSFER PHASE 380 as will be described below.
If the TL counter is less than 2 seconds, the processor enters the WALKING mode SWING PHASE 316 and begins stimulating selected nerve fibers at 318. At 320, the processor determines if there is a heel contact event. If not, the processor determines if the user'"'"'s thigh angle indicates that the user is walking on a stair at 334. If not, the processor determines if a time-out event has occurred at 336. If there is no time-out, the processor returns to 320 to detect the occurrence of the next heel contact event.
Once a heel contact event is determined at 320, the processor enters the WALKING mode STANCE PHASE 322. At 324, the processor then resets a toe lift event counter and turns stimulation off at 326. The processor then determines at 330 whether a toe lift event has occurred. If not, the processor proceeds to 332 and determines if a time-out has occurred. If a time-out does occur, processor returns to the ready state 308. If a time-out has not occurred, the processor prepares to detect the next toe lift event 330. Once the toe lift event at 330 occurs, the processor proceeds to the WALKING mode SWING PHASE 316, described above. If it is determined at 334 that the thigh angle indicates that the user is on a stair, then the processor proceeds to 374 where it is determined if a toe lift event has occurred. If so, the processor proceeds to a STAIR ASCENT SUPPORT PHASE 354 and stimulation is turned off at 356 so that stimulation is not applied while the patient is supporting weight with the affected leg while standing on a stair. At 360, it is determined if a toe lift event has occurred. If not, the processor determines at 358 if a time-out has occurred until either the toe lift event at 360 occurs or the time-out occurs. If the time-out at 358 occurs, the processor returns to the READY mode 308.
Once the toe lift event at 360 is detected, the processor determines if the user'"'"'s thigh indicates they are on a stair at 362. If so, the processor returns to the STAIR ASCENT mode SUPPORT PHASE 354 as indicated above. If not, the processor enters the STAIR ASCENT mode TRANSFER PHASE 364 wherein stimulation is applied at 366 until a determination is made that a heel contact event occurs at 368. If so, the processor enters the WALKING mode STANCE PHASE 322 as described above. If no heel contact event is detected at 368, it is determined at 370 whether a toe lift event has occurred. If no toe lift is detected at 370, it is determined if a timer has expired at 372. If not, the processor determines again if a heel contact event occurs at 368. If the timer checked at 372 has timed out, the processor returns to the READY mode 308. If a toe lift event occurs at 370, it is determined whether the thigh indicates that the user is standing on a stair at 404. If so, the processor enters the STAIR ASCENT SUPPORT PHASE 354 described above. If the thigh angle indicates that the user is not standing on a stair, the processor returns to the STAIR ASCENT TRANSFER PHASE 364 described above.
If the toe lift counter has a duration that is greater than 2 seconds, then the processor enters the STAIR DESCENT TRANSFER PHASE 380, wherein stimulation is applied at 382 and the processor determines if a heel contact event occurs at 384. If a heel contact event does occur, the processor enters the WALKING STANCE PHASE 322. If no heel contact event is detected at 384, the processor determines if a toe lift event occurs at 386. If so, the processor enters the STAIR DESCENT SUPPORT PHASE 392. If no toe lift event at 386 is detected, the processor determines if a time-out occurs at 390. If so, processor enters the READY MODE. If not, the processor returns to detect a heel contact event at 384. If a time-out does occur at 390, the processor turns off the stimulation at 400 and resets the toe lift counter to zero at 402 and returns to READY mode 308.
In the STAIR DESCENT SUPPORT PHASE 392, the stimulation is turned off at 394 and the processor determines if a toe lift event occurs at 396. If so, the processor returns to STAIR DESCENT TRANSFER PHASE 380. If not, the processor determines if a time-out has occurred at 398. If a time-out at 398 does occur, the processor resets the toe lift counter to zero at 402 before returning to the READY mode 308.
As indicated above, the user may desire to operate the nerve stimulation system in an EXERCISE mode by placing the magnet over the control unit for greater than 10 seconds. If detected at 340, the processor enters the EXERCISE mode 344 and turns stimulation on at 346. The presence of the magnet is detected at 348. If no magnet is detected, it is determined if the stimulation has been proceeding for 10 minutes at 350. If not, the processor returns to 348 to detect the presence of the magnet. If either the magnet is present or the stimulation has been proceeding for 10 minutes, stimulation is turned off at 352 and the processor returns to the SLEEP mode 302.
As indicated above, the present embodiment of the closed-loop nerve stimulation system uses two low-power microcontrollers and signal conditioning circuits to detect both when the patient is standing or walking and what type of stimulation patterns should be applied to the nerve fibers, while simultaneously aiming to minimize battery use. To detect the occurrence of a toe lift or heel contact event, the processor executes a toe lift and heel contact detection algorithm described below. The goal of the detection algorithm is to detect a HC or a TL event by processing the amplified, rectified and bin-integrated nerve signal acquired from the tibial or common-peroneal nerve when the embodiments in
A HC or TL event in the amplified, rectified and bin-integrated nerve signal from the tibial or the common peroneal nerve is characterized by a rising or a falling trend of a certain duration and amplitude. On the other hand, this signal may also contain noise consisting of positive or negative spikes that could be of higher amplitude but of shorter duration than the event to be detected.
An HC event can be characterized as:
- a positive ramp longer than a given Minimum Ramp Time, shorter than a given Maximum Ramp Time and a peak-to-baseline difference bigger than a given Threshold. At the same time, negative spikes shorter than a given Maximum Noise Width are ignored;
- or:
- a negative ramp longer than a given Minimum Ramp Time, shorter than a given Maximum Ramp Time and a peak-to-baseline difference bigger than a given Threshold. At the same time, positive spikes shorter than a given Maximum Noise Width are ignored.
A TL event can be characterized as:
- a positive ramp longer than a given Minimum Ramp Time, shorter than a given Maximum Ramp Time and a peak-to-baseline difference bigger than a given Threshold. At the same time, negative spikes shorter than a given Maximum Noise Width are ignored;
- or:
- a negative ramp longer than a given Minimum Ramp Time, shorter than a given Maximum Ramp Time and a peak-to-baseline difference bigger than a given Threshold. At the same time, positive spikes shorter than a given Maximum Noise Width are ignored.
Typically, a HC event is characterized by a positive ramp lasting 50 to 150 milliseconds and a TL event is characterized by a negative ramp lasting 150 to 300 milliseconds.
User selectable/automatic parameters of the event detection algorithm for each event are:
- Ramp Type: {Rising; Falling; OFF}. This parameter is used to define the signal trend that characterizes the event, a rising or a falling ramp. In OFF the signal will not be processed.
- Peak-to-baseline Threshold:{1 to 64}. It is the Signal-Peak-to-Baseline level that must be achieved to detect the event.
- Min Ramp Time: {(4 to 35 samples)*sensing period ms}. Defines the minimum rising or falling time in milliseconds that characterizes the event.
- Max Ramp Time: {(5 to 255 samples)*sensing period ms}. Defines the maximum rising or falling time in milliseconds that characterizes the event.
- Noise Width: {(3 to 6 samples)* sensing period ms}. Defines the maximum width of the spikes to be considered as noise. Noise spikes will be negative for Rising Ramp Type and Positive for Falling Ramp Type.
- Filter Order: Defines the kernel size, 3 to 6 samples, of the morphological filter.
- Bin: {1 to 20 ms} Defines the Bin-integration time.
- Sensing period: {15, 20, 25, 30 ms}.
The amplified, rectified and bin-integrated nerve signal acquired from the tibial or common peroneal nerves is filtered with a morphological filter that is implemented by the processor 150 according to the following expression:
Filter(f,B)=γ(φ(f,B),B) (1)
- where
γ(f,B)=δ(ε(f,B),B) (2)
φ(f,B)=ε(δ(f,B),B) (3) - where
ε(f,B)=minγεBf(y) (4)
ε(f,B)=maxγεBf(y) (5) - where:
- f is the amplified, rectified and bin-integrated signal
- B is the structuring element of the filter, which size is equal to the programmed filtered order value.
- where
When searching for a rising event, the filtered signal (out) is compared to the original signal (f) according to:
out=f−Min(Filter(f,B),f) (6)
When searching for a falling event, the filtered signal is compared to the actual signal (f) according to:
out=Max(Filter(f,B),f)−f (7)
The algorithm to detect a rising event is described in
The algorithm to detect a falling event is described in
The present embodiment of the invention uses a morphological filter because such a filter does not require complicated mathematical operations or sophisticated computing power. However, other filters meeting these same requirements, such as an averaging filter, may also be used.
As shown in
In preferred embodiments, the band-pass amplifier has a single-ended output architecture. While a differential output can be used in the context of the invention and may provide enhanced performance, significant area and power penalties must be paid to achieve those benefits.
Gain programmability may be achieved, as shown in
The differential current generated by transistors M1 is converted into a single-ended current by a cascode configuration, comprising transistors Q5 and cascode mirror M2. With this configuration, better frequency response can be achieved than in the case of an amplifier based on a cascade of two common-source stages. This is particularly true in the case of preamplifier 513, since the parasitic capacitance given by the large input transistors M1 (needed to achieve low-noise) is considerable. Transistor M10 provides further gain and accommodates the biasing of the output stage composed by M11, M12, Q13, and RD. The second stage of preamplifier 513 could comprise a single transistor but, in the preferred embodiment, comprises a transistor M10 with capacitors CM1, and RM providing frequency compensation. See P. R. Gray and R. G. Meyer, “MOS Operational Amplifiers Design—a Tutorial Overview,” IEEE Journal of Solid-State Circuits, sc-17(6):969-982, December 1982.
Finally, the equivalent Darlington pnp transistor M12-Q13 provides very low output impedance while drawing no current from the second stage. See A. R. Alvarez, BiCMOS Technology and Applications, pp. 317-318, 2d ed., Kluwer Academics Publishers, 1993. In this way, preamplifier 513 provides negligible systematic offset independent of variations in the electrical characteristics of the fabrication process. This is important for the successful performance of a DDA.
The transistors may be sized according to the methods presented by F. Silveira, D. Flandre and P. Jespers, “A gm/ID Based Methodology for the Design of CMOS Analog Circuits and Its Application to the Synthesis of a Silicon-On-Insulator Micropower OTA,” IEEE Journal of Solid-State Circuits, 31(9):1314-1319, September 1996. These methods are based on the relation of the transconductance over drain current ratio (gm/ID), to the normalized current (ID/(W/L)) and allow a unified treatment of all regions of operation of the MOSFET transistors. Sizing of the transistors can be achieved for example by using this method and the EKV model, with a set of parameters and measurements from the process. See E. A. Vittoz, Micropower Techniques, Design of Analog-Digital VLSI Circuits for Telecommunications and Signal Processing, pp. 53 67, Eds. J. E. Franca and Y. P. Tsividis, Prentice Hall, 1993; and C. C. Enz et al., “An Analytical MOS Transistor Model Valid in All Regions of Operation and Dedicated to Low-Voltage and Low-Power Applications,” Analog Integrated Circuits and Signal Processing, 8:83-114, 1995.
A main specification that applies to the preamplifier 513 is its noise level. The equivalent total input noise spectral density S1 has the following expression:
The factors in equation (1) are as follows:
- SM1 represents the noise contribution of an M1 input transistor. There are four of these transistors contributing directly to the input noise. The noise of preamplifier 513 is dominated by this factor.
- SR2 represents the noise contribution of resistance R2 that passes directly to the inputs 512.
- SM2 represents the noise contribution of a M2 current mirror transistor. The contribution of these loads is reduced by the square of the ratio of their transconductance to that of the input transistors
- SRa represents the noise contribution of a Ra resistor. The contribution of these resistors is also reduced by the square of the product of their value and the transconductance of the input transistors M1.
- S1/gm is the noise of the equivalent resistor of the gm−C high-pass filter. S1/gm is reduced by two factors. First of all, it is reduced by the gain of the preamplifier 513 (AcDDA), since this stage precedes the filter, and second it decreases with frequency as stated in equation (1). This decrease is logical since, after the high-pass filter poleFHPF the capacitor C can be seen as a short circuit. This places the equivalent resistor 1/gm in parallel with resistor R1.
A rough calculation shows that, in order to maintain a noise level from thermal sources which does not exceed approximately 0.6 μVrms in a 10 kHz bandwidth, the total equivalent input noise should be {square root}{square root over (Si)}=6 nV/{square root}{square root over (Hz)}. Since in a well-designed amplifier the input transistors dominate the noise, the required level of MOSFET transconductance can be achieved only near weak inversion. The selection of the MOSFET type for the input transistors M1 was studied in detail. It is well known that in strong inversion the flicker noise of a PMOS transistor is lower than that of NMOS transistors. However, it has been reported that flicker noise in PMOS transistors may significantly increase when such transistors move from strong inversion toward weak inversion. See D. M. Binkley et al., “A Micropower CMOS, Direct-Conversion, VLF Receiver Chip, for Magnetic-Field Wireless Applications,” IEEE Journal of Solid-State Circuits, 33(3):344-358, March 1998. Still others have reported the flicker noise going down, indicating that it arises from a mechanism that is strongly affected by details of device fabrication. The very severe increase in flicker noise has not been observed in prototype circuits according to this invention. Therefore, transistors M1 may be PMOS in some embodiments of the invention. In embodiments in which the band-pass amplifying circuit is fabricated using an N-well technology, this selection improves the PSRR of the circuit as well.
By implementing the transfer function of the band-pass amplifying circuit and the noise equation given by equation (1) in the MATLAB® design environment, thermal noise levels for each factor were assigned. This approach led to a value of (gm/ID)=16.81 V−1 for the input transistors M1, that corresponds to a (W/L)=4480. Common-centroid crossed-coupling layouts may be used for transistors M1, R. P. Jindal, “Noise Associated with Distributed Resistance of MOSFET Gate Structures in Integrated Circuits,” IEEE Transactions on Electron Devices, ed-31(10):1505-1509, October 1984, describes some common-centroid crossed-coupling layouts.
The load M2 in a prototype circuit according to the invention resulted deep in strong inversion because its transconductance was chosen almost five times lower than that of the input transistors to minimize noise. This resulted in a (W/L)=74.5. Resistors Ra were dimensioned based on biasing requirements, noise minimization, and the folded cascode requirement that gM5Ra>>1. This integrated resistor is made of a p+ diffusion, with a typical value in the range of 64 to 96 to Ω/□ (ohms per square). In the currently preferred embodiment, Ra has a value of 2245 Ω.
The CMRR of the embodiment of preamplifier 13 shown in
- where RoM3 is the output impedance of the cascode current source formed by transistors M3, ΔgM1 is the mismatch between the transconductances of transistors M1, μ1 is the voltage gain of transistors M1, and Δμ1 is the mismatch between the voltage gains of such transistors. Based on mismatch measurements previously performed for the present technology, the size of transistor M4 may be chosen to be (W/L)=20.3. Transistor M3 is composed of a few transistors M4 in order to provide the necessary bias current level for the input transistors M1. In this way, the CMRR given by equation (2) is mainly determined by the mismatch in the voltage gain μ1. CMRRs in the order of 95 dB can be achieved.
The output stage formed by M 11, M12, Q13, and RD, may be designed based on the excursion expected at output 514. Amplified EMG signals caused by mismatches in nerve cuffs as well as random offset of the preamplifier 513 should be taken into account.
The design of the second stage composed by M9, M10, CM1, and RM was based on the minimization of systematic offset and the phase margin desired for the preamplifier 513. In a prototype circuit according to the invention, transistors Q5-Q13 have an emitter area of 6.4×9.6 μm2.
The connection of capacitor CM1 between reference voltage 522 and the gate of one of the M2 transistors, as shown in
As mentioned above, band-pass amplifier 515 may be implemented by cascading two high-PSRR, first-order band-pass amplifiers, each composed of a gm−C high-pass filter and a low-pass amplifying circuit. In
Finally, in this invention, the DC restoration stage is implemented by an RC high-pass filter instead of the gmo—Co high-pass filter mentioned before. The nominal cutoff frequency is preferably around 1300 Hz. This further helps to reduce noise of biological origin while allowing band-pass amplifying circuit to recover within a few milliseconds from overload such as could be caused by stimulation currents or while being cycled on/off. In the present invention, the cycling on/off of the amplifiers Ai is preferably achieved by activating/deactivating the biasing currents 526, 527 in
In addition to the low-power, low-noise amplifiers Ai described above, the signal conditioning circuits 180 also use precision rectifiers and bin integration circuits.
In this invention, the reference signal (Vref) is provided by sensing reference circuit 174. Output 637 of polarity judgment circuit (C) is connected to a control input 638 of switching circuit (SC). A first output 639 of switching circuit (SC) is connected to a first non-inverting input (P1) of a DDA. A second output 640 of switching circuit (SC) is connected to a first inverting input (P2) of the DDA. The second input 632 is also connected to a second non-inverting input (Q1) of the DDA. An output 641 of the DDA is connected to a second inverting input (Q2) of the DDA.
Switching circuit (SC) alternates between, its two states to provide DDA connection patterns 650 and 651 depending upon whether the source signal (Vin) is more positive than or less positive than the reference, signal (Vref) as determined by polarity judgment circuit (C). For example, when the source signal (Vin) is at a potential which is more positive than the reference signal (Vref), configuration pattern 650 is selected. When the source signal (Vin) is at a potential which is more negative than the reference signal (Vref), configuration pattern 651 is selected. For positive half-wave rectification, when source signal (Vin) is more negative than reference signal (Vref), a third configuration pattern may be selected in which reference signal (Vref) is connected to both inputs (P1, P2) of the first differential pair, and the second differential pair remains as connected in
A drain 663 of the first switching element (M1) and a drain of the second switching element (M2) are connected to the non-inverting input (P1) of the first differential pair of the DDA. A drain of the third switching element (M3) and a drain of the fourth switching element (M4) are connected to the inverting input (P2) of this first differential pair of the DDA. The output 637 of the polarity judgment circuit (C) is connected to the input 664 of an inverter (T) and to a gate of the second switching element (M2) and a gate of the third switching element (M3). The complementary output 665 of the polarity judgment circuit (C) is provided by inverter (T) and is connected to a gate 662 of the first switching element (M1) and a gate of the fourth switching element (M4).
In
A DDA 670 which may be used to practice the invention is shown in
For positive full-wave rectification, the DDA produces an output signal with voltage as follows:
- If Vin>Vref then Vout=Vin
- If Vin<Vref then Vout=−Vin
For negative full-wave rectification, the DDA produces an output signal with voltage as follows:
- If Vin>Vref then Vout=−Vin
- If Vin<Vref then Vout=Vin
Since the situation where Vin=Vref is not important, a greater than equal condition (≧) is equivalent to a greater than condition (>) and a less than equal condition (≦) is equivalent to a less than condition (<). The DDA may optionally be configured to amplify its output signal by some gain factor.
As shown in the DDA equations above, when the source signal (Vin) is more positive than the reference signal (Vref), the output signal (Vout) is equal to the source signal (Vin). When the source signal (Vin) is more negative than the reference signal (Vref), the symmetric condition to the one described above happens, resulting in output signal (Vout) being equal to the negative value of the source signal (−Vin). Therefore, the output signal (Vout) is the positive rectified version of the source signal (Vin). Alternatively, if a negative rectified output is desired, the connections to the inputs 635, 636 of the polarity judgment circuit (C) can be reversed such that the source signal (Vin) is connected to the non-inverting input 636 and the reference signal (Vref) is connected to the inverting input 635 of polarity judgment circuit (C). This alternate configuration yields the second set of DDA equations above for the negative full-wave rectification.
Preferred embodiments of the invention require only a small die area because it is not necessary to use any resistors or floating diodes. Consequently, the invention can be fully integrated on a chip in CMOS technology. A low threshold voltage allows circuits according to the invention to be used to rectify low level bioelectrical signals such as signals picked up by nerve cuff electrodes. The full integration of a rectifying circuit having a low threshold voltage enables embodiments of the invention to be especially suitable for use in implantable biomedical devices. For example, a chip which bears a rectifier circuit according to the invention may be incorporated in an implantable device for rectifying nerve signals collected by electrodes for use in a system for manipulating a prosthetic device. A further benefit of requiring only a small die area is that several rectifier circuits of the invention can be integrated into the same implantable device together with other circuits. For example, one or more rectifying circuits according to the invention may be combined with one or more signal conditioning circuits such as amplifiers, filters, or the like on a single integrated circuit chip, which may be a CMOS chip.
As will be apparent to those skilled in the art in the light of the foregoing disclosure, many alterations and modifications are possible in the practice of the invention without departing from the spirit or scope thereof. For example:
- the first and second switch sets (S1, S2) are each shown in the embodiment of
FIG. 11D as comprising two switching elements, however the first and second switch sets (S1, S2) can be configured in a variety of ways, including as a plurality of switching elements, and - any of FETs M1, M2, M3 or M4 may be replaced with other suitable electronic switches which, in their “ON” states offer sufficiently low thresholds.
- the first and second switch sets (S1, S2) are each shown in the embodiment of
As will be apparent to those skilled in the art in the light of the foregoing disclosure, many alterations and modifications are possible in the practice of this invention without departing from the spirit or scope thereof. Accordingly, the scope of the invention is to be construed in accordance with the substance defined by the following claims.